S&W Seed (SANW) 10-Q 13 Feb 25 2025 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Dec. 31, 2024	Feb. 10, 2025
Cover [Abstract]
Entity Registrant Name	S&W SEED CO
Entity Central Index Key	0001477246
Document Type	10-Q
Document Period End Date	Dec. 31, 2024
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity File Number	001-34719
Entity Tax Identification Number	27-1275784
Entity Address, Address Line One	2101 Ken Pratt Blvd
Entity Address, Address Line Two	Suite 201
Entity Address, City or Town	Longmont
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80501
City Area Code	720
Local Phone Number	506-9191
Entity Common Stock, Shares Outstanding		2,145,132
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Trading Symbol	SANW
Title of 12(b) Security	Common Stock, par value $0.001 per share
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	NV
Document Quarterly Report	true
Document Transition Report	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 1,393,200	$ 286,508
Accounts receivable, net	8,371,373	14,636,722
Inventories, net	21,021,310	22,628,343
Prepaid expenses and other current assets	3,412,588	3,431,226
Current assets of discontinued operations	0	22,391,691
TOTAL CURRENT ASSETS	34,198,471	63,374,490
Property, plant and equipment, net	5,732,484	6,127,198
Intellectual property, net	10,610,317	20,265,618
Other intangibles, net	2,386,907	3,206,720
Right of use assets - operating leases	810,018	1,113,833
Equity method investments	18,122,435	19,694,209
Other assets	1,461,381	1,364,532
Non-current assets of discontinued operations	0	5,578,941
TOTAL ASSETS	73,322,013	120,725,541
CURRENT LIABILITIES
Accounts payable	9,459,408	3,255,928
Deferred revenue	4,545,199	832,283
Accrued expenses and other current liabilities	5,147,186	3,770,773
Current portion of working capital lines of credit, net	13,733,741	16,174,537
Current portion of long-term debt, net	267,848	315,304
Current liabilities of discontinued operations	0	44,893,499
TOTAL CURRENT LIABILITIES	33,153,382	69,242,324
Long-term debt, net, less current portion	4,591,207	4,721,849
Other non-current liabilities	585,435	800,620
Non-current liabilities of discontinued operations	0	929,623
TOTAL LIABILITIES	38,330,024	75,694,416
MEZZANINE EQUITY
Preferred stock, $0.001 par value; 3,323 shares authorized; 1,695 issued and outstanding at December 31, 2024 and June 30, 2024	6,028,130	5,768,765
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value; 75,000,000 shares authorized; 2,140,519 issued and 2,139,203 outstanding at December 31, 2024; 2,282,704 issued and 2,281,388 outstanding at June 30, 2024	2,139	43,369
Treasury stock, at cost, 1,316 shares at December 31, 2024 and June 30, 2024	(134,196)	(134,196)
Additional paid-in capital	169,334,593	168,807,072
Accumulated deficit	(140,240,427)	(122,090,479)
Accumulated other comprehensive loss	(39,958)	(7,405,114)
Non-controlling interests	41,708	41,708
TOTAL STOCKHOLDERS' EQUITY	28,963,859	39,262,360
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	73,322,013	120,725,541
MEZZANINE EQUITY
MEZZANINE EQUITY
Preferred stock, $0.001 par value; 3,323 shares authorized; 1,695 issued and outstanding at December 31, 2024 and June 30, 2024	$ 6,028,130	$ 5,768,765

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Dec. 31, 2024	Jun. 30, 2024
STOCKHOLDERS' EQUITY
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	2,140,519	2,282,704
Common stock, shares outstanding	2,139,203	2,281,388
Treasury stock, shares	1,316	1,316
MEZZANINE EQUITY
SERIES B CONVERTIBLE PREFERRED STOCK
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	3,323	3,323
Preferred stock, shares issued	1,695	1,695
Preferred stock, shares outstanding	1,695	1,695

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenue	$ 5,076,898	$ 8,261,308	$ 13,386,374	$ 19,018,655
Cost of revenue (excluding depreciation and amortization shown separately below)	3,194,376	4,728,553	10,167,483	12,759,573
Gross profit	1,882,522	3,532,755	3,218,891	6,259,082
Operating expenses
Selling, general and administrative expenses	4,687,826	4,242,906	8,690,037	8,396,468
Research and development expenses	832,586	723,594	1,574,406	1,502,483
Depreciation and amortization	696,351	818,548	1,510,804	1,625,385
Loss (gain) on disposal of property, plant and equipment	10,022	(48,281)	21,484	(70,373)
Total operating expenses	6,226,785	5,736,767	11,796,731	11,453,963
Loss from operations	(4,344,263)	(2,204,012)	(8,577,840)	(5,194,881)
Other expense (income)
Foreign currency loss (gain)	814	(25,145)	8,739	(24,557)
Interest expense - amortization of debt discount	352,677	347,496	713,815	704,063
Interest expense, net	830,235	712,290	1,592,114	1,510,569
Other (income) expenses	(864)	(59,336)	21,823	(96,896)
Net loss from continuing operations before income taxes	(5,527,125)	(3,179,317)	(10,914,331)	(7,288,060)
Provision for (benefit from) income taxes	1,551	1,833	2,692	(10,460)
Net loss from continuing operations before equity in net earnings of affiliates	(5,528,676)	(3,181,150)	(10,917,023)	(7,277,600)
Equity in loss of equity method investee, net of tax	724,895	577,039	1,571,775	1,354,012
Net loss from continuing operations	(6,253,571)	(3,758,189)	(12,488,798)	(8,631,612)
Net income (loss) from discontinued operations	4,592,714	(2,735,857)	(5,401,785)	(3,819,351)
Net loss	(1,660,857)	(6,494,046)	(17,890,583)	(12,450,963)
Loss attributable to non-controlling interests	0	(25,194)	0	(32,482)
Net loss attributable to S&W Seed Company	(1,660,857)	(6,468,852)	(17,890,583)	(12,418,481)
Calculation of net loss per share
Net Income (Loss)	(1,660,857)	(6,468,852)	(17,890,583)	(12,418,481)
Dividends accrued for participating securities and accretion	(131,473)	(124,431)	(259,365)	(244,476)
Net loss attributable to common shareholders	$ (1,792,330)	$ (6,593,283)	$ (18,149,948)	$ (12,662,957)
Net loss per share from continuing operations, basic	$ (2.73)	$ (1.66)	$ (5.46)	$ (3.81)
Net loss per share from continuing operations diluted	(2.73)	(1.66)	(5.46)	(3.81)
Net income (loss) per share from discontinued operations, basic	2	(1.21)	(2.36)	(1.69)
Net income (loss) per share from discontinued operations, diluted	2	(1.21)	(2.36)	(1.69)
Basic	(0.72)	(2.85)	(7.82)	(5.48)
Diluted	(0.72)	(2.85)	(7.82)	(5.48)
Net loss attributable to common shareholders per common share, basic	(0.78)	(2.91)	(7.94)	(5.59)
Net loss attributable to common shareholders per common share, diluted	$ (0.78)	$ (2.91)	$ (7.94)	$ (5.59)
Weighted average number of common shares outstanding:
Basic	2,291,746	2,267,971	2,287,328	2,265,807
Diluted	2,291,746	2,267,971	2,287,328	2,265,807

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (1,660,857)	$ (6,494,046)	$ (17,890,583)	$ (12,450,963)
Foreign currency translation adjustment, net of income taxes	(9,802)	316,614	(5,741)	155,635
Deconsolidation of subsidiary impact on currency translation adjustment, net of income taxes	0	0	7,370,897	0
Comprehensive loss	(1,670,659)	(6,177,432)	(10,525,427)	(12,295,328)
Comprehensive loss attributable to non-controlling interests	0	(25,194)	0	(32,482)
Comprehensive loss attributable to S&W Seed Company	$ (1,670,659)	$ (6,152,238)	$ (10,525,427)	$ (12,262,846)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interests	Accumulated Other Comprehensive Loss
Mezzanine Equity Beginning Balance, amount at Jun. 30, 2023		$ 5,274,148
Mezzanine Equity Beginning Balance, shares at Jun. 30, 2023		1,695
Beginning Balance, amount at Jun. 30, 2023	$ 68,823,433		$ 43,004	$ (134,196)	$ 167,768,104	$ (91,932,808)	$ 67,120	$ (6,987,791)
Beginning Balance, shares at Jun. 30, 2023			2,263,369	(1,316)
Stock-based compensation, amount	695,147				695,147
Mezzanine equity series B detachable warrant	51,676	$ 51,676
Series B detachable warrant	(51,676)					(51,676)
Mezzanine equity accrued dividends on Series B convertible preferred stock	192,800	192,800
Accrued dividends on Series B convertible preferred stock	(192,800)					(192,800)
Net issuance to settle RSUs, amount	(26,826)		$ 313		(27,139)
Net issuance to settle RSUs, shares			16,476
Cash paid related to stock issuance costs	(165,812)				(165,812)
Other comprehensive income (loss)	155,635							155,635
Net loss	(12,450,963)					(12,418,481)	(32,482)
Ending Balance, amount at Dec. 31, 2023	56,786,138		$ 43,317	$ (134,196)	168,270,300	(104,595,765)	34,638	(6,832,156)
Ending Balance, shares at Dec. 31, 2023			2,279,845	(1,316)
Mezzanine Equity Ending Balance, amount at Dec. 31, 2023		$ 5,518,624
Mezzanine Equity Ending Balance, shares at Dec. 31, 2023		1,695
Mezzanine Equity Beginning Balance, amount at Sep. 30, 2023		$ 5,394,193
Mezzanine Equity Beginning Balance, shares at Sep. 30, 2023		1,695
Beginning Balance, amount at Sep. 30, 2023	62,828,906		$ 43,048	$ (134,196)	168,011,474	(98,002,482)	59,832	(7,148,770)
Beginning Balance, shares at Sep. 30, 2023			2,265,682	(1,316)
Stock-based compensation, amount	283,327				283,327
Mezzanine equity series B detachable warrant		$ 25,838
Series B detachable warrant	(25,838)					(25,838)
Mezzanine equity accrued dividends on Series B convertible preferred stock	98,593	98,593
Accrued dividends on Series B convertible preferred stock	(98,593)					(98,593)
Net issuance to settle RSUs, amount	(11,650)		$ 269		(11,919)
Net issuance to settle RSUs, shares			14,163
Cash paid related to stock issuance costs	(12,582)				(12,582)
Other comprehensive income (loss)	316,614							316,614
Net loss	(6,494,046)					(6,468,852)	(25,194)
Ending Balance, amount at Dec. 31, 2023	56,786,138		$ 43,317	$ (134,196)	168,270,300	(104,595,765)	34,638	(6,832,156)
Ending Balance, shares at Dec. 31, 2023			2,279,845	(1,316)
Mezzanine Equity Ending Balance, amount at Dec. 31, 2023		$ 5,518,624
Mezzanine Equity Ending Balance, shares at Dec. 31, 2023		1,695
Mezzanine Equity Beginning Balance, amount at Jun. 30, 2024	5,768,765	$ 5,768,765
Mezzanine Equity Beginning Balance, shares at Jun. 30, 2024		1,695
Beginning Balance, amount at Jun. 30, 2024	39,262,360		$ 43,369	$ (134,196)	168,807,072	(122,090,479)	41,708	(7,405,114)
Beginning Balance, shares at Jun. 30, 2024			2,282,704	(1,316)
Stock-based compensation, amount	520,010				520,010
Cash paid to purchase common stock, amount	$ (30,000)		$ (200)		(29,800)
Cash paid to purchase common stock, shares			(200,000)
Issuance of common stock for cash upon exercise of stock options, shares	0
Mezzanine equity series B detachable warrant	$ 51,676	$ 51,676
Series B detachable warrant	(51,676)					(51,676)
Mezzanine equity accrued dividends on Series B convertible preferred stock	207,689	207,689
Accrued dividends on Series B convertible preferred stock	(207,689)					(207,689)
Reverse stock split adjustment			$ (41,115)		41,115
Net issuance to settle RSUs, amount	(3,719)		$ 85		(3,804)
Net issuance to settle RSUs, shares			57,815
Deconsolidation of subsidiary	7,370,897							7,370,897
Other comprehensive income (loss)	(5,741)							(5,741)
Net loss	(17,890,583)					(17,890,583)
Ending Balance, amount at Dec. 31, 2024	28,963,859		$ 2,139	$ (134,196)	169,334,593	(140,240,427)	41,708	(39,958)
Ending Balance, shares at Dec. 31, 2024			2,140,519	(1,316)
Mezzanine Equity Ending Balance, amount at Dec. 31, 2024	6,028,130	$ 6,028,130
Mezzanine Equity Ending Balance, shares at Dec. 31, 2024		1,695
Mezzanine Equity Beginning Balance, amount at Sep. 30, 2024		$ 5,896,657
Mezzanine Equity Beginning Balance, shares at Sep. 30, 2024		1,695
Beginning Balance, amount at Sep. 30, 2024	30,521,192		$ 43,398	$ (134,196)	169,048,535	(138,448,097)	41,708	(30,156)
Beginning Balance, shares at Sep. 30, 2024			2,284,226	(1,316)
Stock-based compensation, amount	276,101				276,101
Cash paid to purchase common stock, amount	(30,000)		$ (200)		(29,800)
Cash paid to purchase common stock, shares			(200,000)
Mezzanine equity series B detachable warrant		$ 25,838
Series B detachable warrant	(25,838)					(25,838)
Mezzanine equity accrued dividends on Series B convertible preferred stock	105,635	105,635
Accrued dividends on Series B convertible preferred stock	(105,635)					(105,635)
Reverse stock split adjustment			$ (41,115)		41,115
Net issuance to settle RSUs, amount	(1,302)		$ 56		(1,358)
Net issuance to settle RSUs, shares			56,293
Other comprehensive income (loss)	(9,802)							(9,802)
Net loss	(1,660,857)					(1,660,857)
Ending Balance, amount at Dec. 31, 2024	28,963,859		$ 2,139	$ (134,196)	$ 169,334,593	$ (140,240,427)	$ 41,708	$ (39,958)
Ending Balance, shares at Dec. 31, 2024			2,140,519	(1,316)
Mezzanine Equity Ending Balance, amount at Dec. 31, 2024	$ 6,028,130	$ 6,028,130
Mezzanine Equity Ending Balance, shares at Dec. 31, 2024		1,695

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (17,890,583)	$ (12,450,963)
Net loss from discontinued operations	(5,401,785)	(3,819,351)
Net loss from continuing operations	(12,488,798)	(8,631,612)
Adjustments to reconcile net loss from operating activities to net cash used in operating activities:
Stock-based compensation	520,010	677,507
Provision for credit losses	237,500	506,382
Inventory write-down	294,548	679,266
Depreciation and amortization	1,510,804	1,625,385
Loss (gain) on disposal of property, plant and equipment	21,484	(70,373)
Equity in loss of equity method investees, net of tax	1,571,775	1,354,012
Foreign currency transactions	8,286	(24,454)
Amortization of debt discount	713,815	704,063
Accretion of note receivable	0	(127,476)
Changes in:
Accounts receivable	6,023,133	3,589,426
Receivable from unconsolidated subsidiary	(358,790)	(681,050)
Inventories	(4,628,393)	(4,263,483)
Prepaid expenses and other current assets	789,800	1,014,579
Other non-current assets	(258,909)	(3,266)
Accounts payable	6,219,965	2,355,799
Payable to unconsolidated subsidiary	189,042	(691,243)
Deferred revenue	3,712,916	5,047,740
Accrued expenses and other current liabilities	1,277,937	(1,214,967)
Other non-current liabilities	3,050	27,892
Net cash provided by operating activities from continuing operations	5,359,175	1,874,127
Net cash used in operating activities from discontinuing operations	(1,434,917)	(437,303)
Net cash (used in) provided by operating activities	2,692,408	2,749,712
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment	(195,047)	(234,404)
Proceeds from disposal of property, plant and equipment	39,300	136,589
Net cash used in investing activities from continuing operations	(155,747)	(97,815)
Net cash provided by (used in) investing activities from discontinuing operations	25,079	(906,825)
Net cash used in investing activities	(130,668)	(1,004,640)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings and repayments on lines of credit, net	(2,545,453)	(4,037,200)
Borrowings of long-term debt	0	227,322
Repayments of long-term debt	(196,396)	(80,456)
Payments of debt issuance costs	(1,326,678)	(41,323)
Cash paid to purchase common stock	(30,000)	0
Net proceeds from sale of common stock	0	(165,812)
Taxes paid related to net share settlements of stock-based compensation awards	(3,719)	(26,825)
Net cash used in financing activities from continuing operations	(4,102,246)	(4,124,294)
Net cash provided by financing activities from discontinued operations	1,409,838	1,374,582
Net cash provided by (used) in financing activities	(3,924,258)	(1,436,824)
EFFECT OF EXCHANGE RATE CHANGES ON CASH	5,510	33,107
NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS	1,106,692	(2,284,421)
CASH AND CASH EQUIVALENTS, beginning of the period	286,508	3,398,793
CASH AND CASH EQUIVALENTS, end of period	1,393,200	1,114,372
Cash paid during the period for:
Interest	1,520,044	2,119,009
Income taxes	$ 25	$ 22,225

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (1,660,857)	$ (6,468,852)	$ (17,890,583)	$ (12,418,481)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

General

General	6 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL	NOTE 1 - GENERAL S&W Seed Company, or the Company, is a global multi-crop, middle-market agricultural company that is principally engaged in breeding, growing, processing and selling agricultural seeds. The Company operates seed cleaning and processing facilities in Texas, with its seed products primarily grown under contract by farmers. The Company is currently focused on growing sales of its proprietary and traited products, specifically through the expansion of Double Team ® for forage and grain sorghum products and new trait introductions, including the second generation of Double Team and Prussic Acid Free TM , improving profit margins through pricing and operational efficiencies, and developing the camelina market via a partnership formed in fiscal 2023. The Company's vision is to empower the farming community with superior sorghum germplasm and innovative traits. S&W Australia On July 24, 2024, the Company's wholly-owned subsidiary S&W Seed Company Australia Pty Ltd., or S&W Australia, adopted a voluntary plan of administration based on its determination that S&W Australia was likely to become “insolvent” within the meaning of section 436A(1) of Australia’s Corporations Act 2001. As a result of the voluntary administration process, effective July 24, 2024, the Company no longer controlled S&W Australia for accounting purposes and as such, S&W Australia was deconsolidated from the Company's financial statements as of July 24, 2024. On October 11, 2024, creditors of S&W Australia approved a proposed Deed of Company Arrangement, or DOCA, pursuant to which, among other things, the outstanding shares of S&W Australia would be transferred to Avior Asset Management No. 3 Pty Ltd. In order to facilitate the satisfaction of certain conditions to the effectiveness of the DOCA, on November 22, 2024, the Company entered into (i) a Business Transfer Agreement, (ii) a Transitional Services Deed, and (iii) a Deed of Settlement and Release with S&W Australia. The Company also entered into a Deed of Release of U.S. Corporate Guarantee with National Australia Bank Limited, or NAB, which released the Company from all liability under S&W Australia's finance agreement with NAB, and obtained a release of certain applicable liens from CIBC Bank USA, or CIBC. Business Transfer Agreement Under the Business Transfer Agreement, the Company transferred certain intellectual property rights related to alfalfa and white clover seeds necessary for S&W Australia’s continued operations, or the IP Rights, with a carrying value of $ 9.7 million, along with certain related inventory valued at approximately $ 5.9 million, to S&W Australia. Pursuant to the agreement, S&W Australia granted the Company a non-exclusive, non-transferable, royalty-bearing license to the IP Rights for the sale of products in the United States, Mexico, Canada, Central America, and South America for a term of five years. S&W Australia is entitled to receive a royalty in the mid-single digits from the Company on gross revenue generated from the licensed IP Rights. Transitional Services Deed Under the Transitional Services Deed, the Company agreed to continue providing certain services it has generally provided to S&W Australia on a temporary basis to support the transition of services from the Company to S&W Australia. Each party will be responsible for its own transition costs. The services provided per the Transitional Services Deed will terminate between February 22, 2025 and August 31, 2025, unless terminated earlier pursuant to its terms. Deed of Settlement and Release Under the Deed of Settlement and Release, in consideration for the Company’s (i) transfers under the Business Transfer Agreement, (ii) services rendered under the Transitional Services Deed and (iii) certain other payments, S&W Australia released the Company from all its net intercompany liabilities and obligations owed to S&W Australia, which equated to a net liability of $ 15.3 million as of November 22, 2024. Deed of Release of U.S. Corporate Guarantee Under the Deed of Release of U.S. Corporate Guarantee, NAB released the Company from all liability under S&W Australia's finance agreement with NAB, which was guaranteed by the Company up to a maximum of AUD $ 15.0 million, or the Parent Guarantee. The fair value of this guarantee as of September 30, 2024 was $ 5.0 million, which the Company had recorded in its Condensed Consolidated Balance Sheets. Lien Release Pursuant to the Company’s Amended CIBC Loan Agreement, CIBC obtained a security interest in the Company’s assets. In connection with the execution of the agreements listed above, CIBC consented to the transfer of, and released its security interests in, the assets of the Company to be transferred to S&W Australia pursuant to the Business Transfer Agreement as described above. Discontinued Operations As discussed in Note 3 - Discontinued Operations, effective July 24, 2024, the Company no longer controlled S&W Australia for accounting purposes and as such, deconsolidated this subsidiary. This met the criteria to be accounted for as a discontinued operation as required by Accounting Standards Codification, or ASC, 205-20, Discontinued Operations . Accordingly, the financial results of S&W Australia are reported as discontinued operations in the accompanying unaudited Condensed Consolidated Statements of Operations for all periods presented. Consistent with ASC 205-20, Discontinued Operations , because the sale of S&W Australia was completed on November 22, 2024, the Company will continue presenting the discontinued operations for comparative periods. The gain or loss recognized from the sale is reconciled in Note 3 - Discontinued Operations. All amounts and disclosure included in the accompanying notes to the Condensed Consolidated Financial Statements reflect only the Company's continuing operations unless otherwise noted. Reverse Stock Split A reverse stock split of all issued and outstanding shares of the Company's common stock, at a ratio of 1-for-19 , or the Reverse Stock Split, was implemented at 5:00 p.m. Eastern Time on October 17, 2024. The Company has retroactively adjusted all share amounts and per share data herein to give effect to the Reverse Stock Split. Refer to Note 11 - Equity for additional information on the Reverse Stock Split. Basis of Presentation The accompanying Condensed Consolidated Financial Statements are unaudited and, in the Company’s opinion, include all adjustments, consisting of normal recurring adjustments and accruals, necessary for a fair statement of the Company’s condensed consolidated balance sheets, statements of operations, comprehensive loss, cash flows and mezzanine equity and stockholders’ equity for the periods presented. Operating results for the periods presented are not necessarily indicative of the results to be expected for the full year ending June 30, 2025. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles, or GAAP, have been omitted in accordance with the rules and regulations of the Securities and Exchange Commission, or SEC. These Condensed Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Annual Report on Form 10-K for the fiscal year ended June 30, 2024, as filed with the SEC on November 1, 2024. The Company has reportable segments that correspond with its operating model, management structure, and internal reporting reviewed by its Chief Operating Decision Maker, Mark Herrmann, the Company's President and Chief Executive Officer. The Company's Chief Operating Decision Maker allocates resources and assesses performance based on these segments. Effective with the loss of control of S&W Australia on July 24, 2024, this was reduced to two operating segments, each its own reportable segment, Americas and International. The Company previously had one additional operating and reportable segment, AUSDOM, which related to the Australian domestic business and was included in discontinued operations for the six months ended December 31, 2024 and is presented as such for all periods in this report. Refer to Note 10 - Business Segments for additional information regarding the Company's reportable segments. Certain prior period information has been reclassified to conform to the current period presentation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are adjusted to reflect actual experience when necessary. Significant estimates and assumptions affect many items in the financial statements. In the Annual Report on Form 10-K for the year ended June 30, 2024 filed with this SEC on November 1, 2024, this included the recoverability of long-lived assets and inventory valuation. Significant estimates and assumptions are also used to establish the fair value and useful lives of depreciable tangible and certain intangible assets as well as valuing stock-based compensation. Actual results may differ from those estimates and assumptions, and such results may affect income, financial position or cash flows. The Company believes the estimates and assumptions underlying the accompanying Condensed Consolidated Financial Statements are reasonable and supportable based on the information available at the time the financial statements were prepared. However, certain adverse geopolitical and macroeconomic events, such as the ongoing conflict between Ukraine and Russia and related sanctions, changing U.S. and foreign trade policies, including increased trade restrictions or tariffs, and uncertain market conditions, including higher inflation and supply chain disruptions, have, among other things, negatively impacted the global economy, created significant volatility and disruption of financial markets, and significantly increased economic and demand uncertainty. These factors make many of the estimates and assumptions reflected in these Condensed Consolidated Financial Statements inherently less certain. Therefore, actual results may ultimately differ from those estimates to a greater degree than historically.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Liquidity and Going Concern The Company is not profitable and has recorded negative cash flows from operating activities for the last several years. For the six months ended December 31, 2024, the Company reported a net loss from continuing operations of $ 12.5 million and a net loss from discontinued operations of $ 5.4 million, which included a $ 5.2 million loss from the disposal of S&W Australia. The Company has an accumulated deficit of $ 140.2 million as of December 31, 2024. As of December 31, 2024, the Company had cash on hand of $ 1.4 million and positive working capital of $ 1.0 million. The Company had $ 1.6 million of unused availability from its new working capital facility with ABL OPCO LLC, or Mountain Ridge, as of December 31, 2024. For further information on the Company's new debt facility with Mountain Ridge, refer to Note 9 - Debt. The Company's Credit and Security Agreement, or the Mountain Ridge Credit Agreement, with Mountain Ridge contains various financial covenants. Adverse geopolitical and macroeconomic events and other factors affecting the Company’s results of operations may increase the risk of the Company’s inability to comply with these covenants, which could result in acceleration of its repayment obligations and foreclosure on its pledged assets. As of December 31, 2024, the Company was in compliance with all covenants in the Mountain Ridge Credit Agreement. While we obtained waivers for certain defaults and covenants of our credit facilities in the past, there can be no assurance we will be successful in meeting our covenants, avoiding future defaults, or securing future waivers and/or amendments from our lenders. If we are unsuccessful in doing so, we may need to reduce the scope of our operations, repay amounts owing to our lenders, finance our cash needs through a combination of equity and debt financings, enter into collaborations, strategic alliances and licensing arrangements, delay payments to our growers, sell certain assets or divest certain operations. These operating and liquidity factors raise substantial doubt regarding the Company’s ability to continue as a going concern. The Company’s Condensed Consolidated Financial Statements do not include any adjustments that might result from the outcome of this uncertainty. Cost of Revenue The Company records purchasing and receiving costs, inspection costs and warehousing costs in Cost of revenue. When the Company is required to pay for outward freight and/or the costs incurred to deliver products to its customers, the costs are included in Cost of revenue. Cash and Cash Equivalents For financial statement presentation purposes, the Company considers time deposits, certificates of deposit and all highly liquid investments with original maturities of three month s or less to be cash and cash equivalents. At times, cash and cash equivalents balances exceed amounts insured by the Federal Deposit Insurance Corporation. Cash balances located outside of the United States may not be insured and totaled $ 0.0 million on December 31, 2024 and June 30, 2024. Cash balances residing in the United States exceeding the Federal Deposit Insurance Corporation limit of $ 250,000 totaled $ 1.1 million and $ 0.0 million on December 31, 2024 and June 30, 2024, respectively. International Operations The Company translates its foreign operations’ assets and liabilities denominated in foreign currencies into U.S. dollars at the current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of accumulated other comprehensive loss. Gains or losses from foreign currency transactions are included in the Condensed Consolidated Statements of Operations. For the three months and six months ended December 31, 2024 and 2023, the Co mpany recognized the following foreign currency transaction gains or losses in Cost of revenue and Foreign currency loss (gain) within Other expense (income) in the Condensed Consolidated Statements of Operations: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Cost of revenue $ — $ 337 $ ( 453 ) $ 103 Foreign currency loss (gain) 814 ( 25,145 ) 8,739 ( 24,557 ) Total $ 814 $ ( 24,808 ) $ 8,286 $ ( 24,454 ) Accounts Receivable The Company provides an allowance for credit losses equal to the estimated uncollectible amounts. Prior to July 1, 2023, that estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer’s trade accounts receivable. Effective July 1, 2023, in determining the Company's reserve for credit losses, receivables are assigned an expected loss based on historical information adjusted for forward-looking economic factors. The allowance for credit losses was $ 0.7 million and $ 0.5 million on December 31, 2024 and June 30, 2024, respectively. Inventories Inventories consist of seed and packaging materials. Inventories are stated at the lower of cost or net realizable value, and an inventory reserve permanently reduces the cost basis of inventory. Inventories are valued as follows: Actual cost is used to value raw materials such as packaging materials, as well as goods in process. Costs for substantially all finished goods, which include the cost of carryover crops from the previous year, are valued at actual cost. Actual cost for finished goods includes plant conditioning and packaging costs, direct labor and raw materials and manufacturing overhead costs based on normal capacity. The Company records abnormal amounts of idle facility expense, freight, handling costs and wasted material (spoilage) as current period charges and allocates fixed production overhead to the costs of finished goods based on the normal capacity of the production facilities. Inventory is periodically reviewed to determine if it is marketable, obsolete or impaired. Inventory that is determined to be obsolete or impaired is written off to expense at the time the impairment is identified. Inventory quality is a function of germination percentage. Our experience has shown that our alfalfa seed quality tends to be stable under proper storage conditions; therefore, we do not view inventory obsolescence for alfalfa seed as a material concern. Hybrid crops (sorghum and sunflower) seed quality may be affected by warehouse storage pests such as insects and rodents. The Company maintains a strict pest control program to mitigate risk and maximize hybrid seed quality. Components of inventory are as follows: As of December 31, 2024 As of June 30, 2024 Raw materials and supplies $ 1,292,509 $ 1,324,087 Work in progress 7,744,362 2,305,572 Finished goods 11,984,439 18,998,684 Inventories, net $ 21,021,310 $ 22,628,343 Property, Plant and Equipment Property, plant and equipment is depreciated using the straight-line method over the estimated useful life of the asset - periods of 5 to 35 years for buildings, 3 to 20 years for machinery and equipment, 7 to 10 years for leasehold improvements, and 2 to 5 years for vehicles. Intangible Assets Intangible assets acquired in business acquisitions are reported at their initial fair value less accumulated amortization. Intangible assets are amortized using the straight-line method over the estimated useful life of the asset. Periods of 10 to 30 years for technology/IP/germplasm, 5 to 20 years for customer relationships and trade names, and 10 to 20 years for other intangible assets. Investments The Company has one partnership resulting in a 34 % ownership interest in Vision Bioenergy Oilseeds LLC, or Vision Bioenergy. Following the initial recording of this investment, the Company assesses and records its share of equity earnings from the investment on a quarterly basis, resulting in the investment carrying value increasing or decreasing depending on whether a gain or loss is recorded. Research and Development Costs The Company is engaged in ongoing research and development, or R&D, of proprietary seed varieties. All R&D costs must be charged to expense as incurred. Accordingly, internal R&D costs are expensed as incurred. Third-party R&D costs are expensed when the contracted work has been performed or as milestone results have been achieved. The costs associated with equipment or facilities acquired or constructed for R&D activities that have alternative future uses are capitalized and depreciated on a straight-line basis over the estimated useful life of the asset. Income Taxes Deferred tax assets and liabilities are determined based on differences between the financial statement and tax basis of assets and liabilities, as well as a consideration of net operating loss and credit carry forwards, using enacted tax rates in effect for the period in which the differences are expected to impact taxable income. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company’s effective tax rate for the three and six months ended December 31, 2024 and 2023 ha s been affected by the valuation allowance on the Company’s deferred tax assets. Net Loss Per Common Share Data The Company computes earnings per share using the two-class method. The two-class method requires an earnings allocation formula that determines earnings per share for common shareholders and participating security holders according to dividends declared and participating rights in undistributed earnings. The Company's Series B Preferred Stock and related warrant, or Series B Warrant (see Note 14 - Series B Redeemable Convertible Preferred Stock of the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC), are participating securities because holders of such shares have non-forfeitable dividend rights and participate in any undistributed earnings with common stock. Under the two-class method, total dividends provided to the holders of participating securities and undistributed earnings allocated to participating securities, are subtracted from net loss attributable to the Company in determining net loss attributable to common shareholders in the two-class earnings per share, or EPS, calculation. Accretion to the redemption value for the Series B Preferred Stock is also treated as a deemed dividend and subtracted from net loss attributable to shareholders. There were no undistributed earnings to allocate to the participating securities in the three and six months ended December 31, 2024 and 2023. The calculation of net loss per common share is shown in the table below: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Numerator: Net loss from continuing operations $ ( 6,253,571 ) $ ( 3,758,189 ) $ ( 12,488,798 ) $ ( 8,631,612 ) Net income (loss) from discontinued operations 4,592,714 ( 2,735,857 ) ( 5,401,785 ) ( 3,819,351 ) Net loss ( 1,660,857 ) ( 6,494,046 ) ( 17,890,583 ) ( 12,450,963 ) Loss attributable to non-controlling interests — ( 25,194 ) — ( 32,482 ) Net loss attributable to S&W Seed Company ( 1,660,857 ) ( 6,468,852 ) ( 17,890,583 ) ( 12,418,481 ) Dividends accrued for participating securities ( 105,635 ) ( 98,593 ) ( 207,689 ) ( 192,800 ) Accretion of Series B Preferred Stock redemption value ( 25,838 ) ( 25,838 ) ( 51,676 ) ( 51,676 ) Numerator for net loss per common share - basic and diluted $ ( 1,792,330 ) $ ( 6,593,283 ) $ ( 18,149,948 ) $ ( 12,662,957 ) Denominator: Denominator for basic and diluted net loss per share - weighted average shares 2,291,746 2,267,971 2,287,328 2,265,807 Net loss per common share - basic and diluted $ ( 0.78 ) $ ( 2.91 ) $ ( 7.94 ) $ ( 5.59 ) Anti-dilutive shares, which have been excluded from the computation of diluted loss per share, included 537,966 employee stock options, 74,446 restricted stock units, 89,211 shares issuable upon conversion of the Series B Convertible Preferred Stock, warrants to purchase 138,602 shares of common stock related to the MFP Loan Agreement (as defined below), and 29,440 warrants issued with the Company's Series B Convertible Preferred Stock. The terms and conditions of these securities are more fully described in Note 13 - Equity-Based Compensation and Note 14 - Series B Redeemable Convertible Preferred Stock of the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC. For the three and six months ended December 31, 2024 and 2023 , all potentially dilutive shares were anti-dilutive and excluded from the calculation of diluted loss per share because net losses were recognized. Concentrations One customer accounted for 18 % and another customer accounted for 13 % of the Company's revenue for the three months ended December 31, 2024. One customer accounted for 12 % of the Company's revenue for the six months ended December 31, 2024. One customer accounted for 21 % and another customer accounted for 15 % of the Company's revenue for the three months ended December 31, 2023. One customer accounted for 14 %, a second for 13 %, and a third for 11 % of the Company's revenue for the six months ended December 31, 2023. One customer accounted for 19 % and another customer accounted for 12 % of the Company's accounts receivable as of December 31, 2024 and one customer accounted for 17 % and another customer accounted for an additional 16 % of the Company’s accounts receivable as of June 30, 2024. Sales to international markets represented 5 % and 36 % of revenue during the three months ended December 31, 2024 and 2023, respectively. Sales to international markets represented 42 % and 57 % of revenue during the six months ended December 31, 2024 and 2023, respectiv ely. The net book value of fixed assets located outside the United States w as 0 % of total fixed assets on December 31, 2024 and June 30, 2024, respectively, from continuing operations . Fair Value of Financial Instruments The Company discloses assets and liabilities that are recognized and measured at fair value, presented in a three-tier fair value hierarchy, as follows: • Level 1. Observable inputs such as quoted prices in active markets; • Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and • Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The carrying value of cash and cash equivalents, accounts payable, short-term and all long-term borrowings, as reflected in the condensed consolidated balance sheets, approximate fair value because of the short-term maturity of these instruments or interest rates commensurate with market rates. There have been no changes in operations and/or credit characteristics since the date of issuance that could impact the relationship between interest rate and market rates. As the Company lost control and deconsolidated S&W Australia as a result from the voluntary administration process, the Company must recognize a liability for the fair value of the Parent Guarantee per ASC 460, Guarantees . The Company assessed the fair value of the Parent Guarantee as of July 24, 2024 and elected to record the guarantee at fair value at each reporting date, with any changes in fair value being recorded as a gain or loss in the Company's Condensed Consolidated Statements of Operations. The Company obtained an independent valuation, assigning probabilities under various scenarios and applying estimated recovery and discount rates, which resulted in a $ 5.0 million liability being recorded for the Parent Guarantee under Bank guarantee on the Company's Condensed Consolidated Balance Sheets as of July 24, 2024 and September 30, 2024. The Company determined the fair value of the Parent Guarantee based on a scenario analysis, which included a discount rate ranging between 25.4 % and 35.4 % as of July 24, 2024 and 25.5 % and 35.5 % as of September 30, 2024, and a weighted average recovery rate of 57.8 % as of July 24, 2024 and September 30, 2024. As the Company was released of the Parent Guarantee on November 22, 2024, it removed this liability from its Condensed Consolidated Balance Sheets. In conjunction with the Vision Bioenergy partnership transaction, the Company received a one-time option, or Purchase Option, exercisable at any time on or before the fifth anniversary of the closing of the partnership transaction, to repurchase a 6 % membership interest from Shell. The option repurchase prices range between approximately $ 7.1 and $ 12.0 million, depending on the date on which such purchase is completed. The Purchase Option was valued at $ 0.7 million using a lattice option valuation model. The valuation model incorporated significant, unobservable inputs including a discounted cash flow model based on management projections of future Vision Bioenergy results and an estimate of the current per share value of Vision Bioenergy shares. In the model, the estimate of the current per share value was discounted to account for lack of control and marketability, which were considered to be part of the unit of account given the restrictions of the limited liability com pany agreement that governs the ownership rights of the members. Other unobservable inputs included the risk-free rates and the estimated future stock volatility based on the historical stock price volatilities of other market participants. A full fair value analysis will be performed at each fiscal year-end or when there is an indication that there may be an impairment to the valuation. Management will estimate and adjust the balance for interim periods. A full fair value analysis will be performed whenever there is a potential indicator of impairment to the valuation. No indicators have been identified for the three months ended December 31, 2024 to suggest any material change in the fair value of the purchase option. Quantitative information about Level 3 fair value measurement is as follows: Fair Value as of December 31, 2024 Valuation Technique Unobservable Input Range Purchase Option $ 695,000 Option Model Risk-free rate 3.8 % - 4.9 % Stock price volatility 60 % - 65 % Lack of control premium 13 % Lack of marketability premium 30 % Assets and liabilities that are recognized and measured at fair value on a recurring basis are categorized as follows as of December 31, 2024 and June 30, 2024: Fair Value Measurements as of December 31, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option $ — $ — $ 695,000 Total $ — $ — $ 695,000 Fair Value Measurements as of June 30, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option $ — $ — $ 695,000 Total $ — $ — $ 695,000 Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures, or ASU 2023-07, which requires an enhanced disclosure of segments on an annual and interim basis, including the title of the chief operating decision maker, significant segment expenses, and the composition of other segment items for each segment's reported profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and adoption of ASU 2023-07 should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this standard. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures, or ASU 2023-09, expanding the disclosures requirement for income taxes primarily by requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted and adoption of ASU 2023-09 can be applied prospectively or retrospectively. The Company is currently evaluating the impact of this standard. We have evaluated all other issued and unadopted Accounting Standards Updates and believe the adoption of these standards will not have a material impact on our condensed consolidated statements of operations, comprehensive income, balance sheets, or cash flows.

Discontinued Operations

Discontinued Operations	6 Months Ended
	Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	NOTE 3 - DISCONTINUED OPERATIONS On July 24, 2024, S&W Australia adopted a voluntary plan of administration based on its determination that it was likely to become “insolvent” within the meaning of section 436A(1) of Australia’s Corporations Act 2001. As a result of the voluntary plan of administration, the Company no longer controlled S&W Australia for accounting purposes and as such, S&W Australia was deconsolidated as of July 24, 2024. The expectation at the time was that the Company would not regain control of S&W Australia at the conclusion of the voluntary administration process. This represented a strategic shift given that S&W Australia constituted a material component of the Company's operations, including as one of the Company's reportable segments, AUSDOM, and a material part of another reportable segment, International, for the year ended June 30, 2024. This met the criteria to be accounted for as a discontinued operation as of July 24, 2024 under ASC 205-20, Discontinued Operations . S&W Australia's entry into voluntary administration constituted a reconsideration event, requiring the Company to reassess S&W Australia's status as a Variable Interest Entity, or VIE. The Company deconsolidated the entity because it no longer has the power to direct the activities that most significantly impact the S&W Australia's economic performance. As the Company lost control of but retained its ownership shares in S&W Australia effective July 24, 2024, it met the criteria to be classified as a VIE under ASC 810, Consolidation , with the investment not having any value. The Company was providing limited services and support to S&W Australia as they went through the voluntary administration process, which did not result in a material amount, being less than $ 0.1 million for the six months ended December 31, 2024. When the sale of S&W Australia occurred on November 22, 2024, the only services the Company provided to S&W Australia are what is stipulated in the executed Transitional Services Deed. Consistent with ASC 205-20, Discontinued Operations , because the sale of the subsidiary was completed on November 22, 2024, the Company will continue presenting the discontinued operations for comparative periods. The consideration exchanged, as agreed to per the November 22, 2024 agreements specified in Note 2 - Summary of Significant Accounting Policies, included the release of all the Company's net liabilities and obligations owed to S&W Australia totaling $ 15.3 million and the release of the $ 5.0 million bank guarantee initially recorded as a liability during the three months ended September 30, 2024, partially offset by the Company transferring intangibles assets with a carrying value of $ 9.7 million, inventory with a carrying value of $ 5.9 million to S&W Australia on November 22, 2024, and recognizing a liability for $ 0.1 million related to services provided per the Transitional Services Deed, or TSA Liability. The $ 5.0 million ban k guarantee was recorded as a liability on July 24, 2024, contributing towards the loss recognized during the three months ended September 30, 2024, and following guidance in ASC 460, Guarantees , the Company reversed this when it was fully released from liability under the bank guarantee in connection with the executed agreement on November 22, 2024. This resulted in a gain for the three months ended December 31, 2024 as follows: Consideration Net payables retired $ 15,337,620 Bank guarantee released 5,000,000 Intangible assets transferred ( 9,680,861 ) Inventory transferred ( 5,940,879 ) TSA Liability ( 123,166 ) Gain on disposal of subsidiary $ 4,592,714 Accordingly, the operating results of the discontinued operations for the three and six months ended December 31, 2024 and 2023 are presented in the Condensed Consolidated Statements of Operations within Net loss from discontinued operations. For the six months ended December 31, 2024, this includes S&W Australia activity from July 1, 2024 through July 24, 2024, the date the Company no longer controlled and deconsolidated S&W Australia. A reconciliation to Net loss from discontinued operations for the three and six months ended December 31, 2024 and 2023 is as follows: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Revenue $ — $ 2,603,501 $ 842,545 $ 8,278,620 Cost of revenue (excluding depreciation and amortization shown separately below) — 2,847,132 572,862 6,237,264 Gross profit — ( 243,631 ) 269,683 2,041,356 Operating expenses Selling, general and administrative expenses — 1,650,016 276,096 3,283,034 Research and development expenses — 271,054 50,713 578,677 Depreciation and amortization — 257,471 47,660 519,657 Loss (gain) on disposal of property, plant and equipment — ( 20,453 ) 25,696 ( 31,317 ) Total operating expenses — 2,158,088 400,165 4,350,051 Loss from operations — ( 2,401,719 ) ( 130,482 ) ( 2,308,695 ) Other (income) expense (Gain) loss on disposal of subsidiary ( 4,592,714 ) — 5,235,539 — Foreign currency loss (gain) — 269,443 ( 120,877 ) 641,043 Interest expense - amortization of debt discount — 98,521 6,799 197,528 Interest expense, net — 625,702 149,842 1,233,190 Net income (loss) from discontinued operations before income taxes 4,592,714 ( 3,395,385 ) ( 5,401,785 ) ( 4,380,456 ) Benefit from income taxes from discontinued operations — ( 758,818 ) — ( 745,318 ) Net income (loss) from discontinued operations before equity in net earnings of affiliates 4,592,714 ( 2,636,567 ) ( 5,401,785 ) ( 3,635,138 ) Equity in loss of equity method investee, net of tax, from discontinued operations — 99,290 — 184,213 Net income (loss) from discontinued operations $ 4,592,714 $ ( 2,735,857 ) $ ( 5,401,785 ) $ ( 3,819,351 ) The following table presents assets and liabilities of discontinued operations as of June 30, 2024: ASSETS As of June 30, 2024 CURRENT ASSETS Cash and cash equivalents $ 7,506 Accounts receivable, net 6,228,502 Inventories, net 15,478,760 Prepaid expenses and other current assets 676,923 CURRENT ASSETS OF DISCONTINUED OPERATIONS 22,391,691 NON-CURRENT ASSETS Property, plant and equipment, net 3,540,075 Intangibles, net 576,669 Right of use assets - operating leases 1,134,985 Other assets 327,212 NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS 5,578,941 TOTAL ASSETS OF DISCONTINUED OPERATIONS $ 27,970,632 LIABILITIES CURRENT LIABILITIES Accounts payable $ 10,235,898 Deferred revenue 40,456 Accrued expenses and other current liabilities 3,123,721 Current portion of working capital lines of credit, net 27,549,620 Current portion of long-term debt, net 3,943,804 CURRENT LIABILITIES OF DISCONTINUED OPERATIONS 44,893,499 Long-term debt, net, less current portion 151,387 Other non-current liabilities 778,236 NON-CURRENT LIABILITIES OF DISCONTINUED OPERATIONS 929,623 TOTAL LIABILITIES OF DISCONTINUED OPERATIONS $ 45,823,122 The Company recorded a loss on the disposal of S&W Australia of $ 9.8 million on July 24, 2024, which is included within Net loss from discontinued operations in the Condensed Consolidated Statements of Operations for the six months ended December 31, 2024. In accordance with ASC 810, Consolidation , the recorded loss was measured as the excess liabilities over assets in S&W Australia's ledger as of July 24, 2024, less all currency translation adjustments related to S&W Australia, as all unrealized gains and losses must be realized upon deconsolidation. The Company also recognized the fair value of the Parent Guarantee as of September 30, 2024 as a liability, with the offset going to Loss on disposal of subsidiary. Below is a reconciliation of the loss on disposal of S&W Australia as of July 24, 2024: As of July 24, 2024 Realization of currency translation adjustments from accumulated other comprehensive loss $ 7,289,430 Recognition of bank guarantee 5,000,000 S&W Australia total assets 43,168,611 S&W Australia total liabilities ( 45,629,788 ) Loss on disposal of subsidiary $ 9,828,253 A reconciliation of S&W Australia total assets and total liabilities as of July 24, 2024 is as follows: As of July 24, 2024 CURRENT ASSETS Cash and cash equivalents $ 85,876 Accounts receivable, net 6,311,994 Receivable from unconsolidated subsidiary 15,549,595 Inventories, net 15,274,546 Prepaid expenses and other current assets 666,509 TOTAL CURRENT ASSETS 37,888,520 Property, plant and equipment, net 3,322,273 Other intangibles, net 554,850 Right of use assets - operating leases 1,093,946 Other assets 309,022 TOTAL ASSETS $ 43,168,611 CURRENT LIABILITIES Accounts payable $ 9,150,910 Payable to unconsolidated subsidiary 520,213 Deferred revenue 33,047 Accrued expenses and other current liabilities 2,947,985 Current portion of working capital lines of credit, net 28,263,338 Current portion of long-term debt, net 3,828,839 TOTAL CURRENT LIABILITIES 44,744,332 Long-term debt, net, less current portion 127,288 Other non-current liabilities 758,168 TOTAL LIABILITIES $ 45,629,788

Leases

Leases	6 Months Ended
	Dec. 31, 2024
Lessee Disclosure [Abstract]
LEASES	NOTE 4 - LEASES The Company leases office and laboratory space, research plots and equipment used in connection with its operations under various operating and finance leases. The components of lease assets and liabilities as of December 31, 2024 and June 30, 2024 are as follows: Leases Balance Sheet Classification: As of December 31, 2024 As of June 30, 2024 Assets: Right of use assets - finance leases $ 994,539 $ 1,086,667 Accumulated amortization - finance leases ( 569,207 ) ( 499,275 ) Right of use assets - finance leases, net Other assets 425,332 587,392 Right of use assets - operating leases Right of use assets - operating leases 810,018 1,113,833 Total lease assets $ 1,235,350 $ 1,701,225 Liabilities: Current lease liabilities - finance leases Current portion of long-term debt, net $ 291,250 $ 314,980 Current lease liabilities - operating leases Accrued expenses and other current liabilities 314,346 380,492 Long-term portion of lease liabilities - Long-term debt, net, less current portion 159,026 303,395 Long-term portion of lease liabilities - Other non-current liabilities 585,435 800,620 Total lease liabilities $ 1,350,057 $ 1,799,487 The components of lease cost are as follows: Three Months Ended December 31, Six Months Ended December 31, Lease cost: Income Statement Classification: 2024 2023 2024 2023 Operating lease cost Cost of revenue $ 60,766 $ 96,092 $ 121,533 $ 175,666 Operating lease cost Selling, general and administrative expenses 25,993 36,542 59,019 41,052 Operating lease cost Research and development expenses 21,310 71,824 42,619 119,227 Finance lease cost Depreciation and amortization 81,713 90,290 165,088 119,469 Finance lease cost Interest expense, net 26,499 19,998 40,663 30,049 Total lease costs $ 216,281 $ 314,746 $ 428,922 $ 485,463 Maturities of lease liabilities as of December 31, 2024, are as follows: Fiscal Year Operating Leases Finance Leases Remainder of 2025 $ 203,676 $ 162,853 2026 354,960 280,892 2027 241,622 44,615 2028 183,599 — 2029 56,965 — Total lease payments 1,040,822 488,360 Less: Interest ( 141,041 ) ( 38,084 ) Present value of lease liabilities $ 899,781 $ 450,276 The following are the weighted average assumptions used for lease term and discount rate and supplemental cash flow information related to leases as of December 31, 2024: As of December 31, 2024 Operating lease remaining lease term 3.1 years Operating lease discount rate 8.65 % Finance lease remaining lease term 1.4 years Finance lease discount rate 9.49 % Cash paid for operating leases $ 221,650 Cash paid for finance leases $ 191,247

Revenue Recognition

Revenue Recognition	6 Months Ended
	Dec. 31, 2024
Revenues [Abstract]
REVENUE RECOGNITION	NOTE 5 - REVENUE RECOGNITION The Company derives its revenue primarily from the sale of seed products to seed distributors. From time to time, the Company utilizes excess capacity to provide conditioning, treating and packaging services to other seed producers. The Company also derives service revenue from Vision Bioenergy by providing administrative services under a service level agreement. Revenue from seed product sales is recognized at the point in time at which control of the product is transferred to the customer. Generally, this occurs upon shipment of the product. Pricing for such transactions is negotiated and determined at the time the contracts are signed. We have elected the practical expedient that allows us to account for shipping and handling activities as a fulfillment cost, and we accrue those costs when the related revenue is recognized. The Company has certain contracts with customers that offer a limited right of return on certain branded products through the end of the current sales year (September through August). The products must be in an unopened and undamaged state and must be resalable in the sole opinion of the Company to qualify for a refund. The Company uses a historical returns percentage to estimate the refund liability and records a reduction of revenue in the period in which revenue is recognized. ADAMA Collaboration Agreement The Company has an amended collaboration agreement, or the Amended Collaboration Agreement, with Makhteshim Agan of North America, Inc., or ADAMA, dated February 26, 2024, for the development and commercialization of the Double Team Sorghum Weed Control System, or DT, which is comprised of ADAMA’s ACCase herbicide used in concert with the Company’s ACCase tolerant ATS Sorghum product, Double Team Sorghum Cropping Solution. Although the DT product is designed to be used as a system, the Company sells only the Double Team sorghum seed portion of the system and recognizes the revenue consistent with its sales of other seed products. Under the Amended Collaboration Agreement, the Company will only label and promote ATS Sorghum products with ADAMA herbicides, while ADAMA will not sell ACCase herbicides for use on competing ATS Sorghum products. Further, all DT related trademarks are jointly owned by the Company and ADAMA, and each company grants the other a royalty-free license to use these DT related trademarks. The costs of breeding, trait introgression, variety evaluation, performing quality assurance activities and obtaining seed registrations will be borne by the Company while the cost of development, performance evaluation, performing quality assurance activities and obtaining chemical registrations will be borne by ADAMA. The parties have agreed to share all other costs, except those associated with marketing communications. Double Team sorghum seed sales were $ 1.9 million and $ 4.0 million for the three months ended December 31, 2024 and 2023, respectively. Double Team sorghum seed sales were $ 1.8 million and $ 4.5 million for the six months ended December 31, 2024 and 2023, respectively. Payment Terms and Related Balance Sheet Accounts Accounts receivable represent amounts that are payable to the Company by its customers subject only to the passage of time. Payment terms on invoices are generally 30 to 180 days for export customers and end of sales season (October 31st) for branded products sold within the United States. As the period between the transfer of goods and/or services to the customer and receipt of payment is less than one year , the Company does not separately account for a financing component in its contracts with customers. The Company had $ 0.1 million and $ 0.2 million in unbilled receivables as of December 31 , 2024 and June 30, 2024, respectively, which related to its service level agreement with Vision Bioenergy, as the Company bills Vision Bioenergy on a quarterly basis. Losses on accounts receivable and unbilled receivables are recognized using a forward-looking approach. The Company considers current and expected future economic conditions as well as the performance of borrowers to determine the allowance for credit losses. During the three months ended December 31, 2024 and 2023, the Company recognized bad debt expense of $ 0.4 million and $ 0.3 million, respectively, associated with impaired accounts receivable. During the six months ended December 31, 2024 and 2023, the Company recognized a provision for credit losses of $ 0.2 million and $ 0.5 million, respectively, associated with impaired accounts receivable. Deferred revenue represents payments received from customers in advance of completion of the Company's performance obligation. During the six months ended December 31, 2024 and 2023, the Company recognized $ 0.3 million and $ 0.4 million of revenue, respectively, that was included in the deferred balance as of June 30, 2024 and 2023, respectively. Disaggregation of Revenue The Company disaggregates revenue by type of contract and by destination country. The following table shows revenue from external sources by type of contract: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Seed sales: Alfalfa $ 1,734,054 $ 2,299,360 $ 8,442,056 $ 9,385,730 Sorghum 2,970,610 5,764,167 4,403,468 9,274,134 Other 238,021 21,993 249,245 ( 24,656 ) Services 134,213 175,788 291,605 383,447 Total revenue $ 5,076,898 $ 8,261,308 $ 13,386,374 $ 19,018,655 The following tables show revenue and percentage of revenue from external sources by destination country: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 United States $ 4,800,636 95 % $ 5,248,009 64 % $ 7,735,352 58 % $ 8,262,250 43 % Libya — 0 % 682,200 8 % 1,295,550 10 % 1,755,000 9 % Mexico — 0 % 1,904,895 23 % 1,052,781 8 % 3,467,712 18 % Sudan — 0 % — 0 % 807,530 6 % 1,267,933 7 % South Africa — 0 % — 0 % 533,125 4 % 1,195,553 6 % Egypt — 0 % 348,000 4 % 496,360 4 % 348,000 2 % Uganda — 0 % 289,935 4 % 299,640 2 % 329,935 2 % Morocco — 0 % — 0 % 287,994 2 % — 0 % Bolivia 112,750 2 % — 0 % 180,000 1 % — 0 % Argentina 61,479 1 % — 0 % 150,769 1 % 35,400 0 % Saudi Arabia — 0 % ( 211,185 ) - 3 % — 0 % 1,997,553 11 % Other 102,033 2 % ( 546 ) 0 % 547,273 4 % 359,319 2 % Total revenue $ 5,076,898 100 % $ 8,261,308 100 % $ 13,386,374 100 % $ 19,018,655 100 %

Intangible Assets

Intangible Assets	6 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 6 – INTANGIBLE ASSETS Intangible assets consist of the following: Balance at June 30, 2024 Six Months Ended December 31, 2024 Balance at December 31, 2024 Gross Carrying Amount Accumulated Amortization Net Disposal Amortization Gross Carrying Amount Accumulated Amortization Net Intellectual property $ 33,325,737 $ ( 13,060,119 ) $ 20,265,618 $ ( 9,068,039 ) $ ( 587,262 ) $ 13,491,466 $ ( 2,881,149 ) $ 10,610,317 Trade name 1,831,928 ( 1,178,972 ) 652,956 ( 612,822 ) ( 33,798 ) 232,329 ( 225,992 ) 6,337 Customer relationships 1,596,653 ( 1,019,623 ) 577,030 — ( 45,203 ) 1,596,653 ( 1,064,826 ) 531,827 GI customer list 121,786 ( 93,131 ) 28,655 — ( 3,582 ) 121,786 ( 96,713 ) 25,073 Supply agreement 1,512,667 ( 888,692 ) 623,975 — ( 37,817 ) 1,512,667 ( 926,509 ) 586,158 Grower relationships 2,343,977 ( 1,223,208 ) 1,120,769 — ( 52,703 ) 2,343,977 ( 1,275,911 ) 1,068,066 Internal use software 677,776 ( 474,441 ) 203,335 — ( 33,889 ) 677,776 ( 508,330 ) 169,446 $ 41,410,524 $ ( 17,938,186 ) $ 23,472,338 $ ( 9,680,861 ) $ ( 794,254 ) $ 19,976,654 $ ( 6,979,430 ) $ 12,997,224 As outlined further in Note 3 - Discontinued Operations, the sale of S&W Australia on November 22, 2024 resulted in the Company transferring intangible assets with a carrying value of $ 9.7 million to S&W Australia as consideration provided in this transaction. Of this amount, $ 9.1 million related to intellectual property and $ 0.6 million related to trade names. Amortizatio n expense totaled $ 0.3 million and $ 0.5 million for the three months ended December 31, 2024 and 2023 , respectively. Amortization expense totaled $ 0.8 million and $ 0.9 million for th e six months ended December 31, 2024 and 2023, respectively. Estimated aggregate remaining amortization is as follows: Remainder of 2025 2026 2027 2028 2029 Thereafter Amortization expense $ 458,673 $ 900,605 $ 849,721 $ 795,496 $ 785,319 $ 9,207,410

Property, Plant and Equipment

Property, Plant and Equipment	6 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	NOTE 7 - PROPERTY, PLANT AND EQUIPMENT Components of property, plant and equipment were as follows: As of December 31, 2024 As of June 30, 2024 Land and improvements $ 586,849 $ 586,849 Buildings and improvements 2,365,835 2,371,565 Machinery and equipment 8,784,859 8,621,280 Vehicles 642,929 648,836 Leasehold improvements 473,307 552,810 Construction in progress — 28,453 Total property, plant and equipment 12,853,779 12,809,793 Less: accumulated depreciation ( 7,121,295 ) ( 6,682,595 ) Property, plant and equipment, net $ 5,732,484 $ 6,127,198 Depreciation expense totaled $ 0.3 million and $ 0.3 million for the three months ended December 31, 2024 and 2023 , respectively. Depreciation expense totaled $ 0.6 million and $ 0.5 million for the six months ended December 31, 2024 and 2023, respectively.

Investments

Investments	6 Months Ended
	Dec. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]
Investments	NOte 8 - investments Shell Partnership The terms and conditions of the Contribution and Membership Interest Purchase Agreement, or Purchase Agreement, with Shell relating to the February 6, 2023 partnership for the development and production of sustainable biofuel feedstocks through Vision Bioenergy are presented in Note 7 - Investments to t he Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024. No new activity occurred during the six months ended December 31, 2024. Activity in the period consisted of the recording of the Company's 34 % share of Vision Bioenergy's loss for the period, which is recorded to Equity in loss of equity method investees, net of tax in the Condensed Consolidated Statements of Operations. The summarized unaudited balance sheet presented below reflects the financial information of Vision Bioenergy as of December 31, 2024 and June 30, 2024: As of December 31, 2024 (Unaudited) As of June 30, 2024 (Unaudited) Cash $ 6,804,663 $ 6,327,459 Other current assets 6,944,995 3,138,627 Fixed assets 17,592,974 17,866,091 Intangible assets 18,327,881 19,624,187 Goodwill 11,564,157 11,564,157 Other assets 131,468 235,613 TOTAL ASSETS $ 61,366,138 $ 58,756,134 Current liabilities $ 4,781,810 $ 1,485,283 Long-term liabilities 59,760 133,070 Equity 56,524,568 57,137,781 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 61,366,138 $ 58,756,134 The summarized unaudited income statement presented below reflects the financial information of Vision Bioenergy for the three and six months ended December 31, 2024 and 2023: Three Months Ended December 31, Six Months Ended December 31, 2024 (Unaudited) 2023 (Unaudited) 2024 (Unaudited) 2023 (Unaudited) Revenue $ 355,864 $ 1,074,934 $ 663,635 $ 1,228,924 Gross (loss) profit ( 68,334 ) 619,646 ( 554,606 ) ( 327,005 ) Loss from operations ( 2,160,801 ) ( 1,794,747 ) ( 4,658,726 ) ( 4,624,553 ) Net loss ( 2,126,718 ) ( 1,750,017 ) ( 4,573,213 ) ( 4,509,196 ) The following summarizes the carrying amount of the Company's equity method investments reflected in the Condensed Consolidated Balance Sheets: As of December 31, 2024 As of June 30, 2024 Carrying Amount Economic Interest Carrying Amount Economic Interest Vision Bioenergy $ 18,122,435 34 % $ 19,694,209 34 % Total equity method investments $ 18,122,435 $ 19,694,209 For the six month s ended December 31, 2024, the following activity occurred in the Company's equity method investments: Vision Bioenergy Carrying amount at June 30, 2024 $ 19,694,209 Equity in loss of equity method investment ( 1,571,774 ) Carrying amount at December 31, 2024 $ 18,122,435

Debt

Debt	6 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
DEBT	NOTE 9 - DEBT Total debt outstanding is presented on the Company's Condensed Consolidated Balance Sheets as follows: As of As of Current portion of working capital lines of credit Mountain Ridge $ 13,733,741 $ — CIBC — 16,279,194 Debt issuance costs — ( 104,657 ) Total working capital lines of credit, net $ 13,733,741 $ 16,174,537 Current portion of long-term debt Finance leases $ 291,250 $ 314,980 Vehicle loans - Ford Credit 83,126 106,852 Debt issuance costs ( 106,528 ) ( 106,528 ) Total current portion, net $ 267,848 $ 315,304 Long-term debt, less current portion Finance leases $ 159,026 $ 303,395 Vehicle loans - Ford Credit 182,088 222,063 Secured real estate note - AgAmerica 4,300,000 4,300,000 Debt issuance costs ( 49,907 ) ( 103,609 ) Total long-term portion, net $ 4,591,207 $ 4,721,849 Total debt, net $ 4,859,055 $ 5,037,153 Mountain Ridge Credit Agreement On December 19, 2024 , the Company entered into a Credit and Security Agreement, or the Mountain Ridge Credit Agreement, with ABL OPCO LLC, or Mountain Ridge, as administrative agent, and the lenders party thereto . The Mountain Ridge Credit Agreement provides for a senior secured credit facility of up to $ 25.0 million, or the Mountain Ridge Credit Facility, which matures on February 20, 2026 , provided, how ever, that if on or prior to December 22, 2025 , the maturity date of the term loan agreement entered into on June 20, 2023 between the Company and AgAmerica Lending LLC, or AgAmerica, is extended to a maturity date on or after March 19, 2028 , the maturity date under the Mountain Ridge Credit Agreement will be December 19, 2027 , or the Mountain Ridge Maturity Date. The initial advance under the Mountain Ridge Credit Facility was used to repay in full the Company’s obligations to CIBC pursuant to the Amended and Restated Loan and Security Agreement with CIBC, dated March 22, 2023, as amended, or the CIBC Loan Agreement. Future advances under the Mountain Ridge Credit Facility may be used to finance the Company’s ongoing working capital requirements and other general corporate purposes. Availability of funds under the Mountain Ridge Credit Facility is subject to a borrowing base equal to the sum of (i) up to 95 % of eligible letters of credit, plus (ii) up to 70 % of eligible accounts ( provided , that the maximum amount of eligible accounts that constitute (y) seasonal domestic accounts (after giving effect to the advance rate) which may be included as part of this component of the borrowing base shall not exceed (1) during the calendar months of October, November, December, and January, $ 3.0 million, (2) during the calendar month of February, $ 4.0 million, (C) during the calendar months of March, July, August, and September, $ 5.0 million, or (3) during the calendar months of April, May, and June, $ 6.0 million, or (z) eligible insured foreign accounts (after giving effect to the advance rate) which may be included as part of this component of the borrowing base shall not exceed $ 3.5 million); plus (iii) the lesser of (y) the product of 50 % multiplied by the net orderly liquidation value of eligible inventory, and (z) $ 10.0 million, in each case ((i), (ii) and (iii)), as more fully set forth in the Mountain Ridge Credit Agreement and subject to lender reserves that Mountain Ridge may establish from time to time in its discretion, determined in good faith. Loan advances under the Mountain Ridge Credit Facility bear interest at a rate per annum based on one-month term SOFR plus an applicable margin of 8.0 %. The interest rate under the Mountain Ridge Credit Facility as of December 31, 2024 was 12.53 %. The Company’s obligations under the Mountain Ridge Credit Agreement are secured by a first priority security interest in substantially all of the Company’s assets (subject to certain exceptions), including intellectual property. The Mountain Ridge Credit Agreement contains certain customary representations and warranties, events of default, and affirmative and negative covenants, including limitations with respect to debt, liens, fundamental changes, asset sales, restricted payments, investments and transactions with affiliates, all subject to certain exceptions. Amounts due under the Mountain Ridge Credit Agreement may be accelerated upon an event of default, as defined in the Mountain Ridge Credit Agreement, such as failure to pay amounts owed thereunder when due, breach of a covenant, material inaccuracy of a representation, or occurrence of bankruptcy or insolvency, subject in some cases to cure periods. Additionally, upon the occurrence and during the continuance of an event of default, Mountain Ridge may elect to increase the existing interest rate on all of the Company’s outstanding obligations by 2.0 % per annum. All amounts outstanding under the Mountain Ridge Credit Agreement, including, but not limited to, accrued and unpaid principal and interest due under the Mountain Ridge Credit Facility, will be due and payable in full on the Mountain Ridge Maturity Date. As of December 31, 2024, the Company was in compliance with all financial covenants contained in the Mountain Ridge Credit Agreement. As of December 31, 2024, there was approximately $ 1.6 million of unused availability on the Mountain Ridge Credit Facility, which had an available borrowing base of $ 25.0 million. The Company had $ 1.0 million in debt issuance costs associated with the Mountain Ridge facility, which was capitalized as an asset within Prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets. As of December 31, 2024, $ 0.0 million has been amortized, with $ 1.0 remaining in Prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets to be amortized over the remaining life of the facility. CIBC Loan Agreement On December 26, 2019 , the Company entered into the CIBC Loan Agreement with CIBC, which originally provided for a $ 35.0 million credit facility, or the CIBC Credit Facility. As described in Note 8 - Debt to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ende d June 30, 2024, the CIBC Loan Agreement was subsequently amended on several occasions, including on March 22, 2023, when the Company entered into the Amended CIBC Loan Agreement. During the six months ended December 31, 2024, the Amended CIBC Loan Agreement was amended as follows: • On July 3, 2024, the Company entered into a Third Amendment to the Amended and Restated Loan and Security Agreement, or the Third Amendment, with CIBC, which amended the Amended CIBC Loan Agreement, by and among the Company, as borrower, and CIBC, as administrative agent and sole lead arranger. The Third Amendment, effective as of July 1, 2024, among other things: o subject to the satisfaction of certain post-closing covenants, extended the maturity date from August 31, 2024 to October 31, 2024 , or the Maturity Date; o modified the maximum loan commitment under the Amended CIBC Loan Agreement to (i) $ 20.0 million from July 1, 2024 through July 31, 2024, (ii) $ 18.5 million from August 1, 2024 through September 1, 2024, (iii) $ 17.5 million from September 2, 2024 through September 15, 2024, (iv) $ 15.0 million from September 16, 2024 through October 9, 2024, and (v) $ 13.0 million from October 10, 2024 through the Maturity Date; o modified the eligible inventory sublimit under the Amended CIBC Loan Agreement from $ 5.0 million from July 1, 2024 through August 31, 2024 to (i) $ 8.5 million from July 1, 2024 through July 14, 2024, (ii) $ 7.5 million from July 15, 2024 through August 14, 2024, (iii) $ 7.0 million from August 15, 2024 through September 15, 2024, (iv) $ 6.5 million from September 16, 2024 through September 29, 2024, and (v) $ 5.0 million from September 30, 2024 through the Maturity Date; o added certain post-closing covenants which, should the Company not comply with the amended terms, shall constitute an immediate event of default under the Amended CIBC Loan Agreement; o added a fee of $ 15,000 payable by the Company to CIBC on the date of the Third Amendment; o added a fee of $ 10,000 payable by the Company to CIBC monthly beginning July 1, 2024, and payable only if the eligible inventory sublimit is greater than $ 5.0 million; and o added a fee of $ 25,000 payable by the Company to CIBC on October 1, 2024, and payable only if the Company does not repay the obligations under the Amended CIBC Loan Agreement in full by September 30, 2024. • On October 31, 2024, the Company entered into a Fourth Amendment to the Amended and Restated Loan and Security Agreement with CIBC, or the Fourth Amendment, which amended the Amended CIBC Loan Agreement by and among the Company, as borrower, and CIBC, as administrative agent and sole lead arranger. The Fourth Amendment, effective as of October 31, 2024, among other things: o extended the maturity date from October 31, 2024 to November 30, 2024 , contingent upon the Company's delivery to CIBC of an amended letter of credit issued by JPMorgan Chase Bank, N.A. for the account of MFP, and for the benefit of CIBC, that expires on December 31, 2024, which was delivered on November 8, 2024; and o provided for a fee of $ 25,000 payable by the Company to CIBC on the date of the Fourth Amendment. • On November 29, the Company entered into a Fifth Amendment to the Amended and Restated Loan and Security Agreement with CIBC, or the Fifth Amendment, which amended the Amended CIBC Loan Agreement by and among the Company, as borrower, and CIBC, as administrative agent and sole lead arranger. The CIBC Amendment, effective as of November 29, 2024, among other things: o extended the maturity date from November 30, 2024 to December 13, 2024 , on the condition that the Company delivers to CIBC an amended letter of credit issued by JPMorgan Chase Bank, N.A. for the account of MFP, and for the benefit of CIBC, that expires no earlier than January 13, 2025; and o provided for a fee of $ 40,000 payable by the Company to CIBC on the date of the CIBC Amendment. Except as modified by the Third Amendment, Fourth Amendment and Fifth Amendment, all terms and conditions of the Amended CIBC Loan Agreement remained in full force and effect until the loan was paid off on December 19, 2024. Effective September 16, 2024, and until the loan was paid in full on December 19, 2024, the revolving loan outstanding under the Amended CIBC Loan Agreement (as amended by the Third Amendment) exceeded the total revolving loan commitment thereunder, which constituted an event of default under the Amended CIBC Loan Agreement. On September 18, 2024, the Company received a reservation of rights letter from CIBC asserting the existence of such event of default, increasing the interest rate applicable to the loans by 2.0 % per annum (which is the default rate under the Amended CIBC Loan Agreement), where it remained until the loan was paid off on December 19, 2024. AgAmerica Note As described in Note 8 - Debt to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024, the Company entered into a term loan agreement, or the AgAmerica Loan Agreement, with AgAmerica on June 20, 2023 pursuant to which AgAmerica issued a term loan of $ 4.3 million to the Company and, as security therefor, the Company granted to AgAmerica a mortgage on approximately 31 acres of land located in Lubbock and Moore Counties, Texas, and certain personal property thereon. No changes to this agreement have occurred during the six months ended December 31, 2024. Per the agreement, interest will accrue at a rate per annum equal to 4.85 % plus the Term SOFR Rate , defined as the forward-looking term rate based on the secured overnight financing rate, or SOFR, computed based on the actual number of days elapsed divided by a 360-day year. The annual interest rate as of December 31, 2024 was 9.34 %. Interest payments are due quarterly in arrears, commencing on June 20, 2023, and on the last day of each quarter thereafter, unless otherwise accelerated in accordance with the terms of the AgAmerica Loan Agreement. The AgAmerica Loan Agreement contains certain customary representations and warranties, events of default, and affirmative and negative covenants, including (among others) limitations with respect to liens, fundamental changes, asset sales and formation and acquisition of subsidiaries, subject to certain exceptions. Upon the occurrence of an event of default, and subject to certain cure periods, AgAmerica may declare all outstanding obligations immediately due and payable and take such other actions as set forth in the AgAmerica Loan Agreement, as applicable, provided that in the event of bankruptcy, all such amounts shall automatically become due and payable. Due to the delayed filing of the Annual Report on Form 10-K for the year ended June 30, 2024, the Company was not in compliance with the reporting requirements per the AgAmerica Loan Agreement; however, a waiver was received from AgAmerica for such non-compliance, executed on November 1, 2024. The Company is in compliance with all reporting requirements as of the date of this filing. MFP Loan Agreement On September 22, 2022, the Company’s largest stockholder, MFP, provided a letter of credit issued by JPMorgan Chase Bank, N.A. for the account of MFP, with an initial face amount of $ 9.0 million for the benefit of CIBC, or the MFP Letter of Credit, as additional collateral to support the Company’s obligations under the CIBC Loan Agreement. Concurrently, on September 22, 2022, the Company entered into a Subordinate Loan and Security Agreement with MFP, or the MFP Loan Agreement, pursuant to which any draw CIBC may make on the MFP Letter of Credit will be deemed to be a term loan advance made by MFP to the Company. The MFP Loan Agreement initially provided for up to $ 9.0 million of term loan advances. In connection with the Company’s entry into the Amended CIBC Loan Agreement, the MFP Letter of Credit was amended to increase the maximum amount of term loan advances to $ 13.0 million and extend the maturity date to September 30, 2024 . On July 16, 2024, the Company entered into a Fourth Amendment to Subordinate Loan and Security Agreement with MFP, or the MFP Fourth Amendment, amending the MFP Loan Agreement to (i) extend the maturity date of the letter of credit to November 30, 2024 and (ii) extend the maturity date of the MFP Loan Agreement to May 31, 2025 . On October 31, 2024, the Company entered into a Fifth Amendment to Subordinate Loan and Security Agreement with MFP, or the MFP Fifth Amendment, further amending the MFP Loan Agreement to extend the maturity date of the letter of credit to December 31, 2024 . On November 27, 2024, the Company entered into a Sixth Amendment to Subordinate Loan and Security Agreement with MFP, or the MFP Sixth Amendment, further amending the MFP Loan Agreement to extend the maturity date of the letter of credit to January 31, 2025 in order to satisfy the Fifth Amendment condition for CIBC as discussed above. In connection with the Company’s entry into the Mountain Ridge Credit Agreement, MFP provided a letter of credit, issued by JPMorgan Chase Bank, N.A. for the account of MFP, with a face amount equal to $ 13.0 million for the benefit of Mountain Ridge, or the Second MFP Letter of Credit, as collateral to support the Company’s obligations under the Mountain Ridge Credit Agreement. In addition, the Second MFP Letter of Credit constitutes an eligible letter of credit under the Mountain Ridge Credit Agreement and, therefore, provides the Company with borrowing base credit under the Mountain Ridge Credit Facility. Concurrently with the Company’s entry into the Mountain Ridge Credit Agreement, on December 19, 2024, the Company entered into a Seventh Amendment to Subordinate Loan and Security Agreement with MFP, or the MFP Seventh Amendment, further amending the MFP Loan Agreement to reflect the payoff of the CIBC Loan Agreement and cancellation of the amended letter of credit previously issued by JPMorgan Chase Bank, N.A. for the account of MFP, for the benefit of CIBC, as additional collateral to support the Company’s obligations under the CIBC Loan Agreement, and to reflect and facilitate the issuance of the Second MFP Letter of Credit. The MFP Seventh Amendment also extended the maturity date of the MFP Loan Agreement to July 31, 2028 and the letter of credit to January 31, 2028 . Except as modified by these amendments, all terms and conditions of the MFP Loan Agreement remain in full force and effect. Pursuant to the amended MFP Loan Agreement, the Company accrues a cash fee to be paid to MFP equal to 4.25 % per annum on all amounts remaining undrawn under the Second MFP Letter of Credit. In the event any term advances are deemed made under the MFP Loan Agreement, such advances will bear interest at a rate per annum equal to term SOFR (with a floor of 1.25 %) plus 9.25 %, 50 % of which will be payable in cash on the last day of each fiscal quarter and 50 % of which will accrue as payment in kind interest payable on the maturity date, unless, with respect to any quarterly payment date, the Company elects to pay such interest in cash. As of December 31, 2024, no amounts were outstanding. The MFP Loan Agreement, as amended, includes customary affirmative and negative covenants and events of default and is secured by substantially all of the Company’s assets and is subordinated to the Mountain Ridge Credit Agreement. Upon the occurrence and during the continuance of an event of default, MFP may declare all outstanding obligations under the MFP Loan Agreement immediately due and payable and take such other actions as set forth in the MFP Loan Agreement. Maturities of Long-Term Debt The annual maturities of long-term debt, excluding finance lease liabilities, are as follows: Fiscal Year Amount Remainder of 2025 $ 47,548 2026 4,395,096 2027 95,096 2028 27,474 Total $ 4,565,214

Business Segments

Business Segments	6 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
BUSINESS SEGMENTS	NOTE 10 - BUSINESS SEGMENTS Segment Reporting Prior to the voluntary administration of S&W Australia, the Company had three operating and reportable segments that corresponded with its operating model, management structure, and internal reporting reviewed by its Chief Operating Decision Maker, Mark Herrmann, the Company's President and Chief Executive Officer. Effective with the loss of control of S&W Australia on July 24, 2024, this was reduced to two operating and reportable segments, Americas and International. The Company's Chief Operating Decision Maker currently allocates resources and assesses performance based on these two segments, with the key performance metric utilized being gross profit. Americas : Consists of operations in the United States that results in sales across North and South America. Revenue in the Americas segment is largely made up of sorghum and alfalfa products. International : Consists of operations in the United States that results in sales to countries outside of North and South America. Revenue in the International segment is largely alfalfa products in addition to some sorghum and sunflower products. A large concentration of these sales went to the Middle East and North Africa region. As presented in the table below, Other consists of intercompany activity with S&W Australia. This has historically been eliminated; however, with the deconsolidation of this subsidiary, the activity is no longer eliminated on a go forward basis as of July 24, 2024. Below is a summary of business activity by segment that is reviewed by the Company's Chief Operating Decision Maker for the three and six months ended December 31, 2024 and 2023: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Revenue Americas $ 5,072,734 $ 7,148,131 $ 9,205,668 $ 12,002,183 International 994 1,113,177 4,090,001 7,016,472 Other 3,170 — 90,705 — Revenue 5,076,898 8,261,308 13,386,374 19,018,655 Gross profit (excluding depreciation and amortization) Americas 1,914,232 3,356,633 2,642,495 4,309,295 International ( 23,003 ) 176,122 774,180 1,949,787 Other ( 8,707 ) — ( 197,784 ) — Gross profit (excluding depreciation and amortization) $ 1,882,522 $ 3,532,755 $ 3,218,891 $ 6,259,082 The Company does not allocate Other (income) expense, Equity in loss of equity method investees, net of tax, or Assets by segment as these are not provided to its Chief Operating Decision Maker.

Equity

Equity	6 Months Ended
	Dec. 31, 2024
Equity [Abstract]
EQUITY	NOTE 11 – EQUITY Reverse Stock Split At the Company's special meeting of stockholders held on September 26, 2024, or the Special Meeting, the Company's stockholders approved, pursuant to Nevada Revised Statutes, or NRS, 78.2055, a reverse stock split of the Company's common stock at a ratio in the range of 1-for-5 to 1-for-20 , with such ratio to be determined in the discretion of the Company's board of directors, or Board, and with such reverse stock split to be effected at such time and date as determined by the Board in its sole discretion (but in no event later than January 31, 2025). Following the Special Meeting, on October 4, 2024, the Board unanimously approved, pursuant to NRS 78.2055, a reverse stock split of all issued and outstanding shares of our common stock, at a ratio of 1-for-19 , or the Reverse Stock Split. The Reverse Stock Split was implemented at 5:00 p.m. Eastern Time on October 17, 2024, or the Effective Time. The terms of the Reverse Stock Split are such that every 19 shares of the Company’s issued and outstanding common stock were automatically combined into one issued and outstanding share of common stock, without any change in par value per share. As a result of the Reverse Stock Split, proportionate adjustments were made to the per share exercise price and/or the number of shares issuable upon the exercise or vesting of all then outstanding stock options, restricted stock units and warrants, which resulted in a proportional decrease in the number of shares of the Company's common stock reserved for issuance upon exercise or vesting of such stock options, restricted stock units and warrants, and, in the case of stock options and warrants, a proportional increase in the exercise price of all such stock options and warrants. In addition, the number of shares reserved for issuance under the Company's equity compensation plans immediately prior to the Effective Time was reduced proportionately. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders of record were issued one whole share of common stock in exchange for any fractional interest that such stockholder would have otherwise received as a result of the Reverse Stock Split. The Reverse Stock Split affected all stockholders of record proportionately and did not affect any stockholder’s percentage ownership of the Company’s common stock, except to the extent that the Reverse Stock Split resulted in any stockholder owning an additional share. The Company's common stock began trading on a split-adjusted basis commencing upon market opening on The Nasdaq Capital Market on October 18, 2024. MFP Warrants On September 22, 2022, the Company entered into a Subordinate Loan and Security Agreement, or the MFP Loan Agreement, with MFP, pursuant to which any draw CIBC may make on the MFP Letter of Credit will be deemed to be a term loan advance made by MFP to the Company (see Note 9 - Debt). Pursuant to the terms and conditions of the MFP Loan Agreement and subsequent amendments on October 28, 2022, December 22, 2022 and March 22, 2023, warrants to purchase a total of 138,602 shares of the Company’s common stock were issued to MFP in fiscal 2023. All warrants will expire five years from the date of issuance and have exercise prices ranging from $ 30.40 - $ 40.85 per share. The stated purchase prices of all of the MFP Warrants are subject to adjustment in connection with any stock dividends and splits, distributions with respect to common stock and certain fundamental transactions as described in the MFP Warrant. The MFP Warrants were valued using the Black-Scholes-Merton model as of the respective issue dates and recorded as financial commitment assets within Prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets. The MFP Warrants financial commitment assets are amortized on a straight-line basis over the period from their initial issue dates through the end of the related MFP Letter of Credit commitment periods. During the three months ended December 31, 2024 and 2023, $ 0.0 million and $ 0.2 million, respectively, was amortized as interest expense. During the six months ended December 31, 2024 and 2023, $ 0.2 million and $ 0.4 million, respectively, was amortized as interest expense. MFP is the Company’s largest shareholder. One of the Company’s directors, Alexander C. Matina, was Portfolio Manager of MFP Investors LLC, the general partner of MFP, until December 31, 2023, at which point he transitioned to an advisor role for MFP Investors LLC. Mr. Matina continues to serve on the Board. Stock Purchase from MFP On December 19, 2024, the Company entered into a Stock Purchase Agreement with MFP, or the Stock Purchase Agreement. Pursuant to the Stock Purchase Agreement, the Company repurchased 200,000 shares of the Company’s common stock, or the Repurchased Shares, directly from MFP in a private, non-underwritten transaction. The Repurchased Shares were retired and restored to the status of authorized but unissued shares of the Company. Pursuant to the Stock Purchase Agreement, the Company granted MFP the right to designate one (1) individual, who shall be a representative of MFP reasonably acceptable to the Company, to attend all meetings (whether in person, telephonic or otherwise) of the Board in a non-voting, observer capacity, subject to certain exceptions. MFP has not designated a representative as of December 31, 2024.

Equity-Based Compensation

Equity-Based Compensation	6 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
EQUITY-BASED COMPENSATION	NOTE 12 - EQUITY-BASED COMPENSATION Stock Options The Company utilizes a Black-Scholes-Merton option pricing model, which includes assumptions regarding the risk-free interest rate, dividend yield, life of the award, and the volatility of the Company's common stock to estimate the fair value of employee options grants. Weighted-average assumptions used in the Black-Scholes-Merton model are set forth below for the periods indicated: As of December 31, 2024 2023 Risk free rate 4.14 % 4.45 % - 4.78 % Dividend yield — — Volatility 75.3 % 70.3 %- 70.6 % Forfeiture rate 8.4 % 10.6 % During the six months ended December 31, 2024, the Company granted options to purchase 274,764 shares of its common stock to certain of its directors, members of the executive management team, other employees, and non-employee service providers at exercise price of $ 2.30 per share. These options vest in quarterly periods over three years and expire ten years from the date of grant. A summary of stock option activity for the six months ended December 31, 2024 is presented below: Number of Weighted - Weighted- Aggregate Outstanding at June 30, 2024 279,709 $ 39.18 6.8 $ — Granted 274,764 2.30 — — Exercised — — — — Canceled/forfeited/expired ( 16,507 ) 29.06 — — Outstanding at December 31, 2024 537,966 $ 20.65 7.9 $ — Options vested and exercisable at December 31, 2024 240,756 $ 42.20 5.6 $ — Options vested and expected to vest at December 31, 2024 537,133 $ 20.68 7.9 $ — On December 31, 2024, the Company had $ 0.5 million of unrecognized stock compensation expense, net of estimated forfeitures, related to the options under the S&W Seed Company 2019 Equity Incentive Plan, or 2019 Plan, which will be recognized over the weighted average remaining service period of 2.4 years. The Company settles employee st ock option exercises with newly issued shares of common stock. Restricted Stock Units During the six months ended December 31, 2024 and 2023, the Company issued 70,131 and 47,741 restricted stock units, respectively, to its directors, certain members of the executive management team, other employees, and non-employee service providers. The restricted stock units have varying vesting periods ranging from immediate vesting to quarterly or annual installments over one to three years . The fair value of the awards granted during the six months ended December 31, 2024 and 2023 totaled $ 0.4 million and $ 0.5 million, respectively, and was based on the closing stock price on the date of grants. A summary of activity related to non-vested restricted stock units is presented below: Number of Weighted-Average Weighted-Average Nonvested restricted units outstanding at June 30, 2024 64,602 $ 11.40 1.2 Granted 70,131 11.35 1.3 Vested ( 58,499 ) 10.18 — Forfeited ( 1,790 ) 16.26 — Nonvested restricted units outstanding at December 31, 2024 74,444 $ 6.97 1.2 On December 31, 2024, the Company had $ 0.5 million of unrecognized stock compensation expense related to the restricted stock units, which will be recognized over the weighted average remaining service period of 1.2 years. Stock-based Compensation Expense Stock-based compensation expense recorded for grants of stock options, restricted stock grants and restricted stock units for the three months ended December 31, 2024 and 2023 totaled $ 0.3 million in each period. Stock-based compensation expense recorded for grants of stock options, restricted stock grants and restricted stock units for the six months ended December 31, 2024 and 2023 totaled $ 0.5 million and $ 0.7 million, respectively. On December 31, 2024, there w ere 230,380 share s available under the 2019 Plan for future grants and awards.

Series B Redeemable Convertible

Series B Redeemable Convertible Preferred Stock	6 Months Ended
	Dec. 31, 2024
Temporary Equity Disclosure [Abstract]
Series B Redeemable Convertible Preferred Stock	NOTE 13 – SERIES B REDEEMABLE CONVERTIBLE PREFERRED STOCK The terms and conditions of the Company’s Series B Redeemable Convertible Preferred Stock and accompanying warrant are presented in Note 14 - Series B Redeemable Convertible Preferred Stock to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024. No issuances or conversions of Series B Redeemable Convertible Preferred Stock occurred during the six months ended December 31, 2024. Activity in the period consisted of accrual of dividends and accretion of the discount on the warrants. The following summarizes changes to the Series B Convertible Preferred Stock: Balance at June 30, 2024 $ 5,768,765 Dividends accrued 207,689 Accretion of discount for warrants 51,676 Balance at December 31, 2024 $ 6,028,130

Non-Cash Activities for Stateme

Non-Cash Activities for Statements of Cash Flows	6 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
NON-CASH ACTIVITIES FOR STATEMENTS OF CASH FLOWS	NO TE 14 - NON-CASH ACTIVITIES FOR STATEMENTS OF CASH FLOWS The below table represents supplemental information to the Company’s condensed consolidated statements of cash flows for non-cash activities during the six months ended December 31, 2024 and 2023, respectively, for continuing operations, unless otherwise specified: Six Months Ended December 31, 2024 2023 Non-cash investing activities: ROU assets financed by lease liabilities and lease modifications and reassessments $ ( 96,693 ) $ 1,078,774 Considerations with Avior for transfer of interest in S&W Australia (discontinued operations): Settlement of net payables due to S&W Australia 15,336,849 — Contribution of intangible assets ( 9,680,861 ) — Contribution of inventory ( 5,940,878 ) — Non-cash financing activities: Dividends accrued for participating securities 207,689 192,800 Accretion of discount for Series B preferred stock warrants 51,676 51,676

Subsequent Events

Subsequent Events	6 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 15 - SUBSEQUENT EVENTS Strategic Alternatives Review Process On January 13, 2025, the Company announced that its Board is commencing a process to explore and evaluate various strategic alternatives that may be available to the Company in an effort to enhance shareholder value. The Company expects to consider a broad range of potential opportunities, including, among others, a sale of the Company, a merger with another strategic partner, a recapitalization or continued execution of the Company’s long-term business plan. There are no assurances the review process will result in the Company pursuing any transaction or any other strategic outcome, nor is there a timetable regarding the completion of this process.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are adjusted to reflect actual experience when necessary. Significant estimates and assumptions affect many items in the financial statements. In the Annual Report on Form 10-K for the year ended June 30, 2024 filed with this SEC on November 1, 2024, this included the recoverability of long-lived assets and inventory valuation. Significant estimates and assumptions are also used to establish the fair value and useful lives of depreciable tangible and certain intangible assets as well as valuing stock-based compensation. Actual results may differ from those estimates and assumptions, and such results may affect income, financial position or cash flows. The Company believes the estimates and assumptions underlying the accompanying Condensed Consolidated Financial Statements are reasonable and supportable based on the information available at the time the financial statements were prepared. However, certain adverse geopolitical and macroeconomic events, such as the ongoing conflict between Ukraine and Russia and related sanctions, changing U.S. and foreign trade policies, including increased trade restrictions or tariffs, and uncertain market conditions, including higher inflation and supply chain disruptions, have, among other things, negatively impacted the global economy, created significant volatility and disruption of financial markets, and significantly increased economic and demand uncertainty. These factors make many of the estimates and assumptions reflected in these Condensed Consolidated Financial Statements inherently less certain. Therefore, actual results may ultimately differ from those estimates to a greater degree than historically.
Liquidity and Going Concern	Liquidity and Going Concern The Company is not profitable and has recorded negative cash flows from operating activities for the last several years. For the six months ended December 31, 2024, the Company reported a net loss from continuing operations of $ 12.5 million and a net loss from discontinued operations of $ 5.4 million, which included a $ 5.2 million loss from the disposal of S&W Australia. The Company has an accumulated deficit of $ 140.2 million as of December 31, 2024. As of December 31, 2024, the Company had cash on hand of $ 1.4 million and positive working capital of $ 1.0 million. The Company had $ 1.6 million of unused availability from its new working capital facility with ABL OPCO LLC, or Mountain Ridge, as of December 31, 2024. For further information on the Company's new debt facility with Mountain Ridge, refer to Note 9 - Debt. The Company's Credit and Security Agreement, or the Mountain Ridge Credit Agreement, with Mountain Ridge contains various financial covenants. Adverse geopolitical and macroeconomic events and other factors affecting the Company’s results of operations may increase the risk of the Company’s inability to comply with these covenants, which could result in acceleration of its repayment obligations and foreclosure on its pledged assets. As of December 31, 2024, the Company was in compliance with all covenants in the Mountain Ridge Credit Agreement. While we obtained waivers for certain defaults and covenants of our credit facilities in the past, there can be no assurance we will be successful in meeting our covenants, avoiding future defaults, or securing future waivers and/or amendments from our lenders. If we are unsuccessful in doing so, we may need to reduce the scope of our operations, repay amounts owing to our lenders, finance our cash needs through a combination of equity and debt financings, enter into collaborations, strategic alliances and licensing arrangements, delay payments to our growers, sell certain assets or divest certain operations. These operating and liquidity factors raise substantial doubt regarding the Company’s ability to continue as a going concern. The Company’s Condensed Consolidated Financial Statements do not include any adjustments that might result from the outcome of this uncertainty.
Cost of Revenue	Cost of Revenue The Company records purchasing and receiving costs, inspection costs and warehousing costs in Cost of revenue. When the Company is required to pay for outward freight and/or the costs incurred to deliver products to its customers, the costs are included in Cost of revenue.
Cash and Cash Equivalents	Cash and Cash Equivalents For financial statement presentation purposes, the Company considers time deposits, certificates of deposit and all highly liquid investments with original maturities of three month s or less to be cash and cash equivalents. At times, cash and cash equivalents balances exceed amounts insured by the Federal Deposit Insurance Corporation. Cash balances located outside of the United States may not be insured and totaled $ 0.0 million on December 31, 2024 and June 30, 2024. Cash balances residing in the United States exceeding the Federal Deposit Insurance Corporation limit of $ 250,000 totaled $ 1.1 million and $ 0.0 million on December 31, 2024 and June 30, 2024, respectively.
International Operations	International Operations The Company translates its foreign operations’ assets and liabilities denominated in foreign currencies into U.S. dollars at the current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of accumulated other comprehensive loss. Gains or losses from foreign currency transactions are included in the Condensed Consolidated Statements of Operations. For the three months and six months ended December 31, 2024 and 2023, the Co mpany recognized the following foreign currency transaction gains or losses in Cost of revenue and Foreign currency loss (gain) within Other expense (income) in the Condensed Consolidated Statements of Operations: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Cost of revenue $ — $ 337 $ ( 453 ) $ 103 Foreign currency loss (gain) 814 ( 25,145 ) 8,739 ( 24,557 ) Total $ 814 $ ( 24,808 ) $ 8,286 $ ( 24,454 )
Accounts Receivable	Accounts Receivable The Company provides an allowance for credit losses equal to the estimated uncollectible amounts. Prior to July 1, 2023, that estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer’s trade accounts receivable. Effective July 1, 2023, in determining the Company's reserve for credit losses, receivables are assigned an expected loss based on historical information adjusted for forward-looking economic factors. The allowance for credit losses was $ 0.7 million and $ 0.5 million on December 31, 2024 and June 30, 2024, respectively.
Inventories	Inventories Inventories consist of seed and packaging materials. Inventories are stated at the lower of cost or net realizable value, and an inventory reserve permanently reduces the cost basis of inventory. Inventories are valued as follows: Actual cost is used to value raw materials such as packaging materials, as well as goods in process. Costs for substantially all finished goods, which include the cost of carryover crops from the previous year, are valued at actual cost. Actual cost for finished goods includes plant conditioning and packaging costs, direct labor and raw materials and manufacturing overhead costs based on normal capacity. The Company records abnormal amounts of idle facility expense, freight, handling costs and wasted material (spoilage) as current period charges and allocates fixed production overhead to the costs of finished goods based on the normal capacity of the production facilities. Inventory is periodically reviewed to determine if it is marketable, obsolete or impaired. Inventory that is determined to be obsolete or impaired is written off to expense at the time the impairment is identified. Inventory quality is a function of germination percentage. Our experience has shown that our alfalfa seed quality tends to be stable under proper storage conditions; therefore, we do not view inventory obsolescence for alfalfa seed as a material concern. Hybrid crops (sorghum and sunflower) seed quality may be affected by warehouse storage pests such as insects and rodents. The Company maintains a strict pest control program to mitigate risk and maximize hybrid seed quality. Components of inventory are as follows: As of December 31, 2024 As of June 30, 2024 Raw materials and supplies $ 1,292,509 $ 1,324,087 Work in progress 7,744,362 2,305,572 Finished goods 11,984,439 18,998,684 Inventories, net $ 21,021,310 $ 22,628,343
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment is depreciated using the straight-line method over the estimated useful life of the asset - periods of 5 to 35 years for buildings, 3 to 20 years for machinery and equipment, 7 to 10 years for leasehold improvements, and 2 to 5 years for vehicles.
Intangible Assets	Intangible Assets Intangible assets acquired in business acquisitions are reported at their initial fair value less accumulated amortization. Intangible assets are amortized using the straight-line method over the estimated useful life of the asset. Periods of 10 to 30 years for technology/IP/germplasm, 5 to 20 years for customer relationships and trade names, and 10 to 20 years for other intangible assets.
Investments	Investments The Company has one partnership resulting in a 34 % ownership interest in Vision Bioenergy Oilseeds LLC, or Vision Bioenergy. Following the initial recording of this investment, the Company assesses and records its share of equity earnings from the investment on a quarterly basis, resulting in the investment carrying value increasing or decreasing depending on whether a gain or loss is recorded.
Research and Development Costs	Research and Development Costs The Company is engaged in ongoing research and development, or R&D, of proprietary seed varieties. All R&D costs must be charged to expense as incurred. Accordingly, internal R&D costs are expensed as incurred. Third-party R&D costs are expensed when the contracted work has been performed or as milestone results have been achieved. The costs associated with equipment or facilities acquired or constructed for R&D activities that have alternative future uses are capitalized and depreciated on a straight-line basis over the estimated useful life of the asset.
Income Taxes	Income Taxes Deferred tax assets and liabilities are determined based on differences between the financial statement and tax basis of assets and liabilities, as well as a consideration of net operating loss and credit carry forwards, using enacted tax rates in effect for the period in which the differences are expected to impact taxable income. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company’s effective tax rate for the three and six months ended December 31, 2024 and 2023 ha s been affected by the valuation allowance on the Company’s deferred tax assets.
Net Loss Per Common Share Data	Net Loss Per Common Share Data The Company computes earnings per share using the two-class method. The two-class method requires an earnings allocation formula that determines earnings per share for common shareholders and participating security holders according to dividends declared and participating rights in undistributed earnings. The Company's Series B Preferred Stock and related warrant, or Series B Warrant (see Note 14 - Series B Redeemable Convertible Preferred Stock of the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC), are participating securities because holders of such shares have non-forfeitable dividend rights and participate in any undistributed earnings with common stock. Under the two-class method, total dividends provided to the holders of participating securities and undistributed earnings allocated to participating securities, are subtracted from net loss attributable to the Company in determining net loss attributable to common shareholders in the two-class earnings per share, or EPS, calculation. Accretion to the redemption value for the Series B Preferred Stock is also treated as a deemed dividend and subtracted from net loss attributable to shareholders. There were no undistributed earnings to allocate to the participating securities in the three and six months ended December 31, 2024 and 2023. The calculation of net loss per common share is shown in the table below: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Numerator: Net loss from continuing operations $ ( 6,253,571 ) $ ( 3,758,189 ) $ ( 12,488,798 ) $ ( 8,631,612 ) Net income (loss) from discontinued operations 4,592,714 ( 2,735,857 ) ( 5,401,785 ) ( 3,819,351 ) Net loss ( 1,660,857 ) ( 6,494,046 ) ( 17,890,583 ) ( 12,450,963 ) Loss attributable to non-controlling interests — ( 25,194 ) — ( 32,482 ) Net loss attributable to S&W Seed Company ( 1,660,857 ) ( 6,468,852 ) ( 17,890,583 ) ( 12,418,481 ) Dividends accrued for participating securities ( 105,635 ) ( 98,593 ) ( 207,689 ) ( 192,800 ) Accretion of Series B Preferred Stock redemption value ( 25,838 ) ( 25,838 ) ( 51,676 ) ( 51,676 ) Numerator for net loss per common share - basic and diluted $ ( 1,792,330 ) $ ( 6,593,283 ) $ ( 18,149,948 ) $ ( 12,662,957 ) Denominator: Denominator for basic and diluted net loss per share - weighted average shares 2,291,746 2,267,971 2,287,328 2,265,807 Net loss per common share - basic and diluted $ ( 0.78 ) $ ( 2.91 ) $ ( 7.94 ) $ ( 5.59 ) Anti-dilutive shares, which have been excluded from the computation of diluted loss per share, included 537,966 employee stock options, 74,446 restricted stock units, 89,211 shares issuable upon conversion of the Series B Convertible Preferred Stock, warrants to purchase 138,602 shares of common stock related to the MFP Loan Agreement (as defined below), and 29,440 warrants issued with the Company's Series B Convertible Preferred Stock. The terms and conditions of these securities are more fully described in Note 13 - Equity-Based Compensation and Note 14 - Series B Redeemable Convertible Preferred Stock of the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC. For the three and six months ended December 31, 2024 and 2023 , all potentially dilutive shares were anti-dilutive and excluded from the calculation of diluted loss per share because net losses were recognized.
Concentrations	Concentrations One customer accounted for 18 % and another customer accounted for 13 % of the Company's revenue for the three months ended December 31, 2024. One customer accounted for 12 % of the Company's revenue for the six months ended December 31, 2024. One customer accounted for 21 % and another customer accounted for 15 % of the Company's revenue for the three months ended December 31, 2023. One customer accounted for 14 %, a second for 13 %, and a third for 11 % of the Company's revenue for the six months ended December 31, 2023. One customer accounted for 19 % and another customer accounted for 12 % of the Company's accounts receivable as of December 31, 2024 and one customer accounted for 17 % and another customer accounted for an additional 16 % of the Company’s accounts receivable as of June 30, 2024. Sales to international markets represented 5 % and 36 % of revenue during the three months ended December 31, 2024 and 2023, respectively. Sales to international markets represented 42 % and 57 % of revenue during the six months ended December 31, 2024 and 2023, respectiv ely. The net book value of fixed assets located outside the United States w as 0 % of total fixed assets on December 31, 2024 and June 30, 2024, respectively, from continuing operations .
Fair Values of Financial Instruments	Fair Value of Financial Instruments The Company discloses assets and liabilities that are recognized and measured at fair value, presented in a three-tier fair value hierarchy, as follows: • Level 1. Observable inputs such as quoted prices in active markets; • Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and • Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The carrying value of cash and cash equivalents, accounts payable, short-term and all long-term borrowings, as reflected in the condensed consolidated balance sheets, approximate fair value because of the short-term maturity of these instruments or interest rates commensurate with market rates. There have been no changes in operations and/or credit characteristics since the date of issuance that could impact the relationship between interest rate and market rates. As the Company lost control and deconsolidated S&W Australia as a result from the voluntary administration process, the Company must recognize a liability for the fair value of the Parent Guarantee per ASC 460, Guarantees . The Company assessed the fair value of the Parent Guarantee as of July 24, 2024 and elected to record the guarantee at fair value at each reporting date, with any changes in fair value being recorded as a gain or loss in the Company's Condensed Consolidated Statements of Operations. The Company obtained an independent valuation, assigning probabilities under various scenarios and applying estimated recovery and discount rates, which resulted in a $ 5.0 million liability being recorded for the Parent Guarantee under Bank guarantee on the Company's Condensed Consolidated Balance Sheets as of July 24, 2024 and September 30, 2024. The Company determined the fair value of the Parent Guarantee based on a scenario analysis, which included a discount rate ranging between 25.4 % and 35.4 % as of July 24, 2024 and 25.5 % and 35.5 % as of September 30, 2024, and a weighted average recovery rate of 57.8 % as of July 24, 2024 and September 30, 2024. As the Company was released of the Parent Guarantee on November 22, 2024, it removed this liability from its Condensed Consolidated Balance Sheets. In conjunction with the Vision Bioenergy partnership transaction, the Company received a one-time option, or Purchase Option, exercisable at any time on or before the fifth anniversary of the closing of the partnership transaction, to repurchase a 6 % membership interest from Shell. The option repurchase prices range between approximately $ 7.1 and $ 12.0 million, depending on the date on which such purchase is completed. The Purchase Option was valued at $ 0.7 million using a lattice option valuation model. The valuation model incorporated significant, unobservable inputs including a discounted cash flow model based on management projections of future Vision Bioenergy results and an estimate of the current per share value of Vision Bioenergy shares. In the model, the estimate of the current per share value was discounted to account for lack of control and marketability, which were considered to be part of the unit of account given the restrictions of the limited liability com pany agreement that governs the ownership rights of the members. Other unobservable inputs included the risk-free rates and the estimated future stock volatility based on the historical stock price volatilities of other market participants. A full fair value analysis will be performed at each fiscal year-end or when there is an indication that there may be an impairment to the valuation. Management will estimate and adjust the balance for interim periods. A full fair value analysis will be performed whenever there is a potential indicator of impairment to the valuation. No indicators have been identified for the three months ended December 31, 2024 to suggest any material change in the fair value of the purchase option. Quantitative information about Level 3 fair value measurement is as follows: Fair Value as of December 31, 2024 Valuation Technique Unobservable Input Range Purchase Option $ 695,000 Option Model Risk-free rate 3.8 % - 4.9 % Stock price volatility 60 % - 65 % Lack of control premium 13 % Lack of marketability premium 30 % Assets and liabilities that are recognized and measured at fair value on a recurring basis are categorized as follows as of December 31, 2024 and June 30, 2024: Fair Value Measurements as of December 31, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option $ — $ — $ 695,000 Total $ — $ — $ 695,000 Fair Value Measurements as of June 30, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option $ — $ — $ 695,000 Total $ — $ — $ 695,000
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures, or ASU 2023-07, which requires an enhanced disclosure of segments on an annual and interim basis, including the title of the chief operating decision maker, significant segment expenses, and the composition of other segment items for each segment's reported profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and adoption of ASU 2023-07 should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this standard. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures, or ASU 2023-09, expanding the disclosures requirement for income taxes primarily by requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted and adoption of ASU 2023-09 can be applied prospectively or retrospectively. The Company is currently evaluating the impact of this standard. We have evaluated all other issued and unadopted Accounting Standards Updates and believe the adoption of these standards will not have a material impact on our condensed consolidated statements of operations, comprehensive income, balance sheets, or cash flows.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Schedule of Foreign Currency Transaction (Gains) Loss	For the three months and six months ended December 31, 2024 and 2023, the Co mpany recognized the following foreign currency transaction gains or losses in Cost of revenue and Foreign currency loss (gain) within Other expense (income) in the Condensed Consolidated Statements of Operations: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Cost of revenue $ — $ 337 $ ( 453 ) $ 103 Foreign currency loss (gain) 814 ( 25,145 ) 8,739 ( 24,557 ) Total $ 814 $ ( 24,808 ) $ 8,286 $ ( 24,454 )
Components of Inventory	Components of inventory are as follows: As of December 31, 2024 As of June 30, 2024 Raw materials and supplies $ 1,292,509 $ 1,324,087 Work in progress 7,744,362 2,305,572 Finished goods 11,984,439 18,998,684 Inventories, net $ 21,021,310 $ 22,628,343
Schedule of Calculation of Net Loss Per Common Share	The calculation of net loss per common share is shown in the table below: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Numerator: Net loss from continuing operations $ ( 6,253,571 ) $ ( 3,758,189 ) $ ( 12,488,798 ) $ ( 8,631,612 ) Net income (loss) from discontinued operations 4,592,714 ( 2,735,857 ) ( 5,401,785 ) ( 3,819,351 ) Net loss ( 1,660,857 ) ( 6,494,046 ) ( 17,890,583 ) ( 12,450,963 ) Loss attributable to non-controlling interests — ( 25,194 ) — ( 32,482 ) Net loss attributable to S&W Seed Company ( 1,660,857 ) ( 6,468,852 ) ( 17,890,583 ) ( 12,418,481 ) Dividends accrued for participating securities ( 105,635 ) ( 98,593 ) ( 207,689 ) ( 192,800 ) Accretion of Series B Preferred Stock redemption value ( 25,838 ) ( 25,838 ) ( 51,676 ) ( 51,676 ) Numerator for net loss per common share - basic and diluted $ ( 1,792,330 ) $ ( 6,593,283 ) $ ( 18,149,948 ) $ ( 12,662,957 ) Denominator: Denominator for basic and diluted net loss per share - weighted average shares 2,291,746 2,267,971 2,287,328 2,265,807 Net loss per common share - basic and diluted $ ( 0.78 ) $ ( 2.91 ) $ ( 7.94 ) $ ( 5.59 )
Schedule of Quantitative Information About Level 3 Fair Value Measurement	Quantitative information about Level 3 fair value measurement is as follows: Fair Value as of December 31, 2024 Valuation Technique Unobservable Input Range Purchase Option $ 695,000 Option Model Risk-free rate 3.8 % - 4.9 % Stock price volatility 60 % - 65 % Lack of control premium 13 % Lack of marketability premium 30 %
Schedule of Assets and Liabilities Recognized and Measured at Fair Value on Recurring Basis	Assets and liabilities that are recognized and measured at fair value on a recurring basis are categorized as follows as of December 31, 2024 and June 30, 2024: Fair Value Measurements as of December 31, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option $ — $ — $ 695,000 Total $ — $ — $ 695,000 Fair Value Measurements as of June 30, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option $ — $ — $ 695,000 Total $ — $ — $ 695,000

Discontinued Operations (Tables

Discontinued Operations (Tables)	6 Months Ended
	Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Consideration Exchanged	This resulted in a gain for the three months ended December 31, 2024 as follows: Consideration Net payables retired $ 15,337,620 Bank guarantee released 5,000,000 Intangible assets transferred ( 9,680,861 ) Inventory transferred ( 5,940,879 ) TSA Liability ( 123,166 ) Gain on disposal of subsidiary $ 4,592,714
Summary of the Discontinued Operations	Accordingly, the operating results of the discontinued operations for the three and six months ended December 31, 2024 and 2023 are presented in the Condensed Consolidated Statements of Operations within Net loss from discontinued operations. For the six months ended December 31, 2024, this includes S&W Australia activity from July 1, 2024 through July 24, 2024, the date the Company no longer controlled and deconsolidated S&W Australia. A reconciliation to Net loss from discontinued operations for the three and six months ended December 31, 2024 and 2023 is as follows: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Revenue $ — $ 2,603,501 $ 842,545 $ 8,278,620 Cost of revenue (excluding depreciation and amortization shown separately below) — 2,847,132 572,862 6,237,264 Gross profit — ( 243,631 ) 269,683 2,041,356 Operating expenses Selling, general and administrative expenses — 1,650,016 276,096 3,283,034 Research and development expenses — 271,054 50,713 578,677 Depreciation and amortization — 257,471 47,660 519,657 Loss (gain) on disposal of property, plant and equipment — ( 20,453 ) 25,696 ( 31,317 ) Total operating expenses — 2,158,088 400,165 4,350,051 Loss from operations — ( 2,401,719 ) ( 130,482 ) ( 2,308,695 ) Other (income) expense (Gain) loss on disposal of subsidiary ( 4,592,714 ) — 5,235,539 — Foreign currency loss (gain) — 269,443 ( 120,877 ) 641,043 Interest expense - amortization of debt discount — 98,521 6,799 197,528 Interest expense, net — 625,702 149,842 1,233,190 Net income (loss) from discontinued operations before income taxes 4,592,714 ( 3,395,385 ) ( 5,401,785 ) ( 4,380,456 ) Benefit from income taxes from discontinued operations — ( 758,818 ) — ( 745,318 ) Net income (loss) from discontinued operations before equity in net earnings of affiliates 4,592,714 ( 2,636,567 ) ( 5,401,785 ) ( 3,635,138 ) Equity in loss of equity method investee, net of tax, from discontinued operations — 99,290 — 184,213 Net income (loss) from discontinued operations $ 4,592,714 $ ( 2,735,857 ) $ ( 5,401,785 ) $ ( 3,819,351 ) The following table presents assets and liabilities of discontinued operations as of June 30, 2024: ASSETS As of June 30, 2024 CURRENT ASSETS Cash and cash equivalents $ 7,506 Accounts receivable, net 6,228,502 Inventories, net 15,478,760 Prepaid expenses and other current assets 676,923 CURRENT ASSETS OF DISCONTINUED OPERATIONS 22,391,691 NON-CURRENT ASSETS Property, plant and equipment, net 3,540,075 Intangibles, net 576,669 Right of use assets - operating leases 1,134,985 Other assets 327,212 NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS 5,578,941 TOTAL ASSETS OF DISCONTINUED OPERATIONS $ 27,970,632 LIABILITIES CURRENT LIABILITIES Accounts payable $ 10,235,898 Deferred revenue 40,456 Accrued expenses and other current liabilities 3,123,721 Current portion of working capital lines of credit, net 27,549,620 Current portion of long-term debt, net 3,943,804 CURRENT LIABILITIES OF DISCONTINUED OPERATIONS 44,893,499 Long-term debt, net, less current portion 151,387 Other non-current liabilities 778,236 NON-CURRENT LIABILITIES OF DISCONTINUED OPERATIONS 929,623 TOTAL LIABILITIES OF DISCONTINUED OPERATIONS $ 45,823,122
Schedule of Reconciliation of Loss on Deconsolidation of S&W Australia	Below is a reconciliation of the loss on disposal of S&W Australia as of July 24, 2024: As of July 24, 2024 Realization of currency translation adjustments from accumulated other comprehensive loss $ 7,289,430 Recognition of bank guarantee 5,000,000 S&W Australia total assets 43,168,611 S&W Australia total liabilities ( 45,629,788 ) Loss on disposal of subsidiary $ 9,828,253 A reconciliation of S&W Australia total assets and total liabilities as of July 24, 2024 is as follows: As of July 24, 2024 CURRENT ASSETS Cash and cash equivalents $ 85,876 Accounts receivable, net 6,311,994 Receivable from unconsolidated subsidiary 15,549,595 Inventories, net 15,274,546 Prepaid expenses and other current assets 666,509 TOTAL CURRENT ASSETS 37,888,520 Property, plant and equipment, net 3,322,273 Other intangibles, net 554,850 Right of use assets - operating leases 1,093,946 Other assets 309,022 TOTAL ASSETS $ 43,168,611 CURRENT LIABILITIES Accounts payable $ 9,150,910 Payable to unconsolidated subsidiary 520,213 Deferred revenue 33,047 Accrued expenses and other current liabilities 2,947,985 Current portion of working capital lines of credit, net 28,263,338 Current portion of long-term debt, net 3,828,839 TOTAL CURRENT LIABILITIES 44,744,332 Long-term debt, net, less current portion 127,288 Other non-current liabilities 758,168 TOTAL LIABILITIES $ 45,629,788

Leases (Tables)

Leases (Tables)	6 Months Ended
	Dec. 31, 2024
Lessee Disclosure [Abstract]
Summary of Components of Lease Assets and Liabilities	The components of lease assets and liabilities as of December 31, 2024 and June 30, 2024 are as follows: Leases Balance Sheet Classification: As of December 31, 2024 As of June 30, 2024 Assets: Right of use assets - finance leases $ 994,539 $ 1,086,667 Accumulated amortization - finance leases ( 569,207 ) ( 499,275 ) Right of use assets - finance leases, net Other assets 425,332 587,392 Right of use assets - operating leases Right of use assets - operating leases 810,018 1,113,833 Total lease assets $ 1,235,350 $ 1,701,225 Liabilities: Current lease liabilities - finance leases Current portion of long-term debt, net $ 291,250 $ 314,980 Current lease liabilities - operating leases Accrued expenses and other current liabilities 314,346 380,492 Long-term portion of lease liabilities - Long-term debt, net, less current portion 159,026 303,395 Long-term portion of lease liabilities - Other non-current liabilities 585,435 800,620 Total lease liabilities $ 1,350,057 $ 1,799,487
Summary of Components of Lease Cost	The components of lease cost are as follows: Three Months Ended December 31, Six Months Ended December 31, Lease cost: Income Statement Classification: 2024 2023 2024 2023 Operating lease cost Cost of revenue $ 60,766 $ 96,092 $ 121,533 $ 175,666 Operating lease cost Selling, general and administrative expenses 25,993 36,542 59,019 41,052 Operating lease cost Research and development expenses 21,310 71,824 42,619 119,227 Finance lease cost Depreciation and amortization 81,713 90,290 165,088 119,469 Finance lease cost Interest expense, net 26,499 19,998 40,663 30,049 Total lease costs $ 216,281 $ 314,746 $ 428,922 $ 485,463
Summary of Maturities of Lease Liabilities	Maturities of lease liabilities as of December 31, 2024, are as follows: Fiscal Year Operating Leases Finance Leases Remainder of 2025 $ 203,676 $ 162,853 2026 354,960 280,892 2027 241,622 44,615 2028 183,599 — 2029 56,965 — Total lease payments 1,040,822 488,360 Less: Interest ( 141,041 ) ( 38,084 ) Present value of lease liabilities $ 899,781 $ 450,276
Summary of Weighted Average Assumptions on Lease Term and Discount Rate and Supplemental Cash Flow Information Related to Leases	The following are the weighted average assumptions used for lease term and discount rate and supplemental cash flow information related to leases as of December 31, 2024: As of December 31, 2024 Operating lease remaining lease term 3.1 years Operating lease discount rate 8.65 % Finance lease remaining lease term 1.4 years Finance lease discount rate 9.49 % Cash paid for operating leases $ 221,650 Cash paid for finance leases $ 191,247

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Dec. 31, 2024
Revenues [Abstract]
Schedule of Disaggregation of Revenues	The Company disaggregates revenue by type of contract and by destination country. The following table shows revenue from external sources by type of contract: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Seed sales: Alfalfa $ 1,734,054 $ 2,299,360 $ 8,442,056 $ 9,385,730 Sorghum 2,970,610 5,764,167 4,403,468 9,274,134 Other 238,021 21,993 249,245 ( 24,656 ) Services 134,213 175,788 291,605 383,447 Total revenue $ 5,076,898 $ 8,261,308 $ 13,386,374 $ 19,018,655
Schedule of Revenues and Percentage of Revenue from External Customers by Country	The following tables show revenue and percentage of revenue from external sources by destination country: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 United States $ 4,800,636 95 % $ 5,248,009 64 % $ 7,735,352 58 % $ 8,262,250 43 % Libya — 0 % 682,200 8 % 1,295,550 10 % 1,755,000 9 % Mexico — 0 % 1,904,895 23 % 1,052,781 8 % 3,467,712 18 % Sudan — 0 % — 0 % 807,530 6 % 1,267,933 7 % South Africa — 0 % — 0 % 533,125 4 % 1,195,553 6 % Egypt — 0 % 348,000 4 % 496,360 4 % 348,000 2 % Uganda — 0 % 289,935 4 % 299,640 2 % 329,935 2 % Morocco — 0 % — 0 % 287,994 2 % — 0 % Bolivia 112,750 2 % — 0 % 180,000 1 % — 0 % Argentina 61,479 1 % — 0 % 150,769 1 % 35,400 0 % Saudi Arabia — 0 % ( 211,185 ) - 3 % — 0 % 1,997,553 11 % Other 102,033 2 % ( 546 ) 0 % 547,273 4 % 359,319 2 % Total revenue $ 5,076,898 100 % $ 8,261,308 100 % $ 13,386,374 100 % $ 19,018,655 100 %

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following: Balance at June 30, 2024 Six Months Ended December 31, 2024 Balance at December 31, 2024 Gross Carrying Amount Accumulated Amortization Net Disposal Amortization Gross Carrying Amount Accumulated Amortization Net Intellectual property $ 33,325,737 $ ( 13,060,119 ) $ 20,265,618 $ ( 9,068,039 ) $ ( 587,262 ) $ 13,491,466 $ ( 2,881,149 ) $ 10,610,317 Trade name 1,831,928 ( 1,178,972 ) 652,956 ( 612,822 ) ( 33,798 ) 232,329 ( 225,992 ) 6,337 Customer relationships 1,596,653 ( 1,019,623 ) 577,030 — ( 45,203 ) 1,596,653 ( 1,064,826 ) 531,827 GI customer list 121,786 ( 93,131 ) 28,655 — ( 3,582 ) 121,786 ( 96,713 ) 25,073 Supply agreement 1,512,667 ( 888,692 ) 623,975 — ( 37,817 ) 1,512,667 ( 926,509 ) 586,158 Grower relationships 2,343,977 ( 1,223,208 ) 1,120,769 — ( 52,703 ) 2,343,977 ( 1,275,911 ) 1,068,066 Internal use software 677,776 ( 474,441 ) 203,335 — ( 33,889 ) 677,776 ( 508,330 ) 169,446 $ 41,410,524 $ ( 17,938,186 ) $ 23,472,338 $ ( 9,680,861 ) $ ( 794,254 ) $ 19,976,654 $ ( 6,979,430 ) $ 12,997,224 As outlined further in Note 3 - Discontinued Operations, the sale of S&W Australia on November 22, 2024 resulted in the Company transferring intangible assets with a carrying value of $ 9.7 million to S&W Australia as consideration provided in this transaction. Of this amount, $ 9.1 million related to intellectual property and $ 0.6 million related to trade names.
Estimated Aggregate Remaining Amortization	Estimated aggregate remaining amortization is as follows: Remainder of 2025 2026 2027 2028 2029 Thereafter Amortization expense $ 458,673 $ 900,605 $ 849,721 $ 795,496 $ 785,319 $ 9,207,410

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	6 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Components of Property, Plant and Equipment	Components of property, plant and equipment were as follows: As of December 31, 2024 As of June 30, 2024 Land and improvements $ 586,849 $ 586,849 Buildings and improvements 2,365,835 2,371,565 Machinery and equipment 8,784,859 8,621,280 Vehicles 642,929 648,836 Leasehold improvements 473,307 552,810 Construction in progress — 28,453 Total property, plant and equipment 12,853,779 12,809,793 Less: accumulated depreciation ( 7,121,295 ) ( 6,682,595 ) Property, plant and equipment, net $ 5,732,484 $ 6,127,198

Investments (Tables)

Investments (Tables)	6 Months Ended
	Dec. 31, 2024
Schedule of Equity Method Investments [Line Items]
Summary of Equity Method Investments	The following summarizes the carrying amount of the Company's equity method investments reflected in the Condensed Consolidated Balance Sheets: As of December 31, 2024 As of June 30, 2024 Carrying Amount Economic Interest Carrying Amount Economic Interest Vision Bioenergy $ 18,122,435 34 % $ 19,694,209 34 % Total equity method investments $ 18,122,435 $ 19,694,209
Schedule of Company's Equity Method Investments	For the six month s ended December 31, 2024, the following activity occurred in the Company's equity method investments: Vision Bioenergy Carrying amount at June 30, 2024 $ 19,694,209 Equity in loss of equity method investment ( 1,571,774 ) Carrying amount at December 31, 2024 $ 18,122,435
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Summary of Equity Method Investments	The summarized unaudited balance sheet presented below reflects the financial information of Vision Bioenergy as of December 31, 2024 and June 30, 2024: As of December 31, 2024 (Unaudited) As of June 30, 2024 (Unaudited) Cash $ 6,804,663 $ 6,327,459 Other current assets 6,944,995 3,138,627 Fixed assets 17,592,974 17,866,091 Intangible assets 18,327,881 19,624,187 Goodwill 11,564,157 11,564,157 Other assets 131,468 235,613 TOTAL ASSETS $ 61,366,138 $ 58,756,134 Current liabilities $ 4,781,810 $ 1,485,283 Long-term liabilities 59,760 133,070 Equity 56,524,568 57,137,781 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 61,366,138 $ 58,756,134 The summarized unaudited income statement presented below reflects the financial information of Vision Bioenergy for the three and six months ended December 31, 2024 and 2023: Three Months Ended December 31, Six Months Ended December 31, 2024 (Unaudited) 2023 (Unaudited) 2024 (Unaudited) 2023 (Unaudited) Revenue $ 355,864 $ 1,074,934 $ 663,635 $ 1,228,924 Gross (loss) profit ( 68,334 ) 619,646 ( 554,606 ) ( 327,005 ) Loss from operations ( 2,160,801 ) ( 1,794,747 ) ( 4,658,726 ) ( 4,624,553 ) Net loss ( 2,126,718 ) ( 1,750,017 ) ( 4,573,213 ) ( 4,509,196 )

Debt (Tables)

Debt (Tables)	6 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Total Debt Outstanding	Total debt outstanding is presented on the Company's Condensed Consolidated Balance Sheets as follows: As of As of Current portion of working capital lines of credit Mountain Ridge $ 13,733,741 $ — CIBC — 16,279,194 Debt issuance costs — ( 104,657 ) Total working capital lines of credit, net $ 13,733,741 $ 16,174,537 Current portion of long-term debt Finance leases $ 291,250 $ 314,980 Vehicle loans - Ford Credit 83,126 106,852 Debt issuance costs ( 106,528 ) ( 106,528 ) Total current portion, net $ 267,848 $ 315,304 Long-term debt, less current portion Finance leases $ 159,026 $ 303,395 Vehicle loans - Ford Credit 182,088 222,063 Secured real estate note - AgAmerica 4,300,000 4,300,000 Debt issuance costs ( 49,907 ) ( 103,609 ) Total long-term portion, net $ 4,591,207 $ 4,721,849 Total debt, net $ 4,859,055 $ 5,037,153
Schedule of Annual Maturities of Long-Term Debt Excluding Finance Lease Liabilities	The annual maturities of long-term debt, excluding finance lease liabilities, are as follows: Fiscal Year Amount Remainder of 2025 $ 47,548 2026 4,395,096 2027 95,096 2028 27,474 Total $ 4,565,214

Business Segments (Tables)

Business Segments (Tables)	6 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Summary of Business Activity by Segment	Below is a summary of business activity by segment that is reviewed by the Company's Chief Operating Decision Maker for the three and six months ended December 31, 2024 and 2023: Three Months Ended December 31, Six Months Ended December 31, 2024 2023 2024 2023 Revenue Americas $ 5,072,734 $ 7,148,131 $ 9,205,668 $ 12,002,183 International 994 1,113,177 4,090,001 7,016,472 Other 3,170 — 90,705 — Revenue 5,076,898 8,261,308 13,386,374 19,018,655 Gross profit (excluding depreciation and amortization) Americas 1,914,232 3,356,633 2,642,495 4,309,295 International ( 23,003 ) 176,122 774,180 1,949,787 Other ( 8,707 ) — ( 197,784 ) — Gross profit (excluding depreciation and amortization) $ 1,882,522 $ 3,532,755 $ 3,218,891 $ 6,259,082

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	6 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Weighted Average Assumptions Used in Black-Scholes-Merton Model	Weighted-average assumptions used in the Black-Scholes-Merton model are set forth below for the periods indicated: As of December 31, 2024 2023 Risk free rate 4.14 % 4.45 % - 4.78 % Dividend yield — — Volatility 75.3 % 70.3 %- 70.6 % Forfeiture rate 8.4 % 10.6 %
Summary of Stock Option Activity	A summary of stock option activity for the six months ended December 31, 2024 is presented below: Number of Weighted - Weighted- Aggregate Outstanding at June 30, 2024 279,709 $ 39.18 6.8 $ — Granted 274,764 2.30 — — Exercised — — — — Canceled/forfeited/expired ( 16,507 ) 29.06 — — Outstanding at December 31, 2024 537,966 $ 20.65 7.9 $ — Options vested and exercisable at December 31, 2024 240,756 $ 42.20 5.6 $ — Options vested and expected to vest at December 31, 2024 537,133 $ 20.68 7.9 $ —
Summary of Activity Related to Non-Vested Restricted Stock Units	A summary of activity related to non-vested restricted stock units is presented below: Number of Weighted-Average Weighted-Average Nonvested restricted units outstanding at June 30, 2024 64,602 $ 11.40 1.2 Granted 70,131 11.35 1.3 Vested ( 58,499 ) 10.18 — Forfeited ( 1,790 ) 16.26 — Nonvested restricted units outstanding at December 31, 2024 74,444 $ 6.97 1.2

Series B Redeemable Convertib_2

Series B Redeemable Convertible Preferred Stock (Tables)	6 Months Ended
	Dec. 31, 2024
Temporary Equity Disclosure [Abstract]
Summary of Changes to Series B Convertible Preferred Stock	The following summarizes changes to the Series B Convertible Preferred Stock: Balance at June 30, 2024 $ 5,768,765 Dividends accrued 207,689 Accretion of discount for warrants 51,676 Balance at December 31, 2024 $ 6,028,130

Non-Cash Activities for State_2

Non-Cash Activities for Statements of Cash Flows (Tables)	6 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Condensed Consolidated Statements of Cash Flows for Non-Cash Activities	The below table represents supplemental information to the Company’s condensed consolidated statements of cash flows for non-cash activities during the six months ended December 31, 2024 and 2023, respectively, for continuing operations, unless otherwise specified: Six Months Ended December 31, 2024 2023 Non-cash investing activities: ROU assets financed by lease liabilities and lease modifications and reassessments $ ( 96,693 ) $ 1,078,774 Considerations with Avior for transfer of interest in S&W Australia (discontinued operations): Settlement of net payables due to S&W Australia 15,336,849 — Contribution of intangible assets ( 9,680,861 ) — Contribution of inventory ( 5,940,878 ) — Non-cash financing activities: Dividends accrued for participating securities 207,689 192,800 Accretion of discount for Series B preferred stock warrants 51,676 51,676

General - Additional Informatio

General - Additional Information (Details) $ in Millions	Oct. 17, 2024	Nov. 22, 2024 USD ($)	Nov. 22, 2024 AUD ($)	Sep. 30, 2024 USD ($)	Jul. 24, 2024 USD ($)	Jun. 30, 2024 USD ($)
Discontinued Operations | S&W Seed Company Australia Pty Ltd
Background And Organizations [Line Items]
Carrying value		$ 9,700,000
Inventories, net		5,900,000			$ 15,274,546	$ 15,478,760
S&W Australia total liabilities		$ (15,300,000)			$ (45,629,788)	$ (45,823,122)
Common Stock [Member]
Background And Organizations [Line Items]
Reverse stock split ratio	0.053
National Australia Bank Limited
Background And Organizations [Line Items]
Line of guaranteed, maximum borrowing capacity			$ 15	$ 5,000,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details)			3 Months Ended		6 Months Ended
	Jul. 24, 2024 USD ($)	Feb. 06, 2023 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) shares	Dec. 31, 2023 USD ($)	Nov. 22, 2024 USD ($)	Sep. 30, 2024	Jun. 30, 2024 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Cash balances			$ 1,100,000		$ 1,100,000				$ 0
Bank guarantee			5,000,000		5,000,000
Net loss from continuing operations			6,253,571	$ 3,758,189	12,488,798	$ 8,631,612
Net loss from discontinued operations			(4,592,714)	2,735,857	5,401,785	3,819,351
Accumulated deficit			(140,240,427)		(140,240,427)				(122,090,479)
Cash on hand			1,400,000		1,400,000
Negative working capital			1,000,000		1,000,000
Dividends accrued undistributed earnings to allocate to participating securities			0	0	0	0
Federal deposit cash			250,000		250,000
Mountain Ridge
Summary Of Significant Accounting Policies [Line Items]
Line of credit facility, remaining borrowing capacity			1,600,000		1,600,000
S&W Seed Company Australia Pty Ltd | Discontinued Operations
Summary Of Significant Accounting Policies [Line Items]
Bank guarantee	$ 5,000,000						$ 5,000,000
Net loss from discontinued operations			(4,592,714)	$ 2,735,857	5,401,785	$ 3,819,351
Loss on deconsolidation of subsidiary	$ 9,828,253		(4,592,714)		5,235,539
Shell
Summary Of Significant Accounting Policies [Line Items]
Membership interest repurchase percent		6%
Fair market value of purchase option					$ 700,000
Employee Stock Options
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares					537,966
Series B Convertible Preferred Stock
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares					89,211
Shares of Common Stock Related to MFP Loan Agreement
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares					138,602
Warrants Issued with Series B Convertible Preferred Stock
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares					29,440
Restricted Stock Units (RSUs)
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares					74,446
Non-US
Summary Of Significant Accounting Policies [Line Items]
Cash balances			$ 0		$ 0				$ 0
Minimum | Discount Rate
Summary Of Significant Accounting Policies [Line Items]
Measurement input	25.4							25.5
Minimum | Shell
Summary Of Significant Accounting Policies [Line Items]
Membership interest repurchase price		$ 7,100,000
Minimum | Technology/IP/germplasm
Summary Of Significant Accounting Policies [Line Items]
Useful life					10 years
Minimum | Customer Relationships
Summary Of Significant Accounting Policies [Line Items]
Useful life					5 years
Minimum | Other Intangibles
Summary Of Significant Accounting Policies [Line Items]
Useful life					10 years
Minimum | Buildings
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives			5 years		5 years
Minimum | Machinery and Equipment
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives			3 years		3 years
Minimum | Leasehold improvements
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives			7 years		7 years
Minimum | Vehicles
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives			2 years		2 years
Maximum | Discount Rate
Summary Of Significant Accounting Policies [Line Items]
Measurement input	35.4							35.5
Maximum | Shell
Summary Of Significant Accounting Policies [Line Items]
Membership interest repurchase price		$ 12,000,000
Maximum | Technology/IP/germplasm
Summary Of Significant Accounting Policies [Line Items]
Useful life					30 years
Maximum | Customer Relationships
Summary Of Significant Accounting Policies [Line Items]
Useful life					20 years
Maximum | Other Intangibles
Summary Of Significant Accounting Policies [Line Items]
Useful life					20 years
Maximum | Buildings
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives			35 years		35 years
Maximum | Machinery and Equipment
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives			20 years		20 years
Maximum | Leasehold improvements
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives			10 years		10 years
Maximum | Vehicles
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives			5 years		5 years
Weighted Average | Recovery Rate
Summary Of Significant Accounting Policies [Line Items]
Measurement input	57.8							57.8
Vision Bioenergy
Summary Of Significant Accounting Policies [Line Items]
Sale of ownership interest percentage			34%		34%				34%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Accounts Receivable) - Additional Information (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Accounting Policies [Abstract]
Allowance for credit losses	$ 0.7	$ 0.5

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Concentrations) - Additional Information (Details) - Customer	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Non-US
Summary Of Significant Accounting Policies [Line Items]
Disclosure on geographic areas, fixed assets			The net book value of fixed assets located outside the United States was 0% of total fixed assets on December 31, 2024 and June 30, 2024, respectively, from continuing operations
Concentration of risk fixed assets amount geographic area, percent of total	0%		0%			0%
Revenue | Geographic Concentration Risk | Non-US
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	5%	36%	42%	57%
Customer One | Revenue | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	18%	21%	12%	14%
Customer One | Accounts Receivable | Credit Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			19%		17%
Customer Two | Revenue | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	13%	15%		13%
Customer Two | Accounts Receivable | Credit Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			12%		16%
Customer Three | Revenue | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage				11%
Significant Customer | Revenue | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Number of customers	2	2	1	3
Significant Customer | Accounts Receivable | Credit Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Number of customers			2		2

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Foreign Currency Transaction (Gains) Loss (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gains in cost of revenue and losses in foreign currency loss	$ 814	$ (24,808)	$ 8,286	$ (24,454)
Cost of Revenue
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gains in cost of revenue and losses in foreign currency loss		337	(453)	103
Foreign currency loss (gain)
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gains in cost of revenue and losses in foreign currency loss	$ 814	$ (25,145)	$ 8,739	$ (24,557)

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Components of Inventory (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 1,292,509	$ 1,324,087
Work in progress	7,744,362	2,305,572
Finished goods	11,984,439	18,998,684
Inventories, net	$ 21,021,310	$ 22,628,343

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Schedule of Calculation of Net Loss Per Common Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Numerator:
Net loss from continuing operations	$ (6,253,571)	$ (3,758,189)	$ (12,488,798)	$ (8,631,612)
Net loss from discontinued operations	4,592,714	(2,735,857)	(5,401,785)	(3,819,351)
Net loss	(1,660,857)	(6,494,046)	(17,890,583)	(12,450,963)
Loss attributable to non-controlling interests	0	(25,194)	0	(32,482)
Net loss attributable to S&W Seed Company	(1,660,857)	(6,468,852)	(17,890,583)	(12,418,481)
Dividends accrued for participating securities	(105,635)	(98,593)	(207,689)	(192,800)
Accretion of Series B Preferred Stock redemption value	(25,838)	(25,838)	(51,676)	(51,676)
Numerator for net loss per common share - basic	(1,792,330)	(6,593,283)	(18,149,948)	(12,662,957)
Numerator for net loss per common share - diluted	$ (1,792,330)	$ (6,593,283)	$ (18,149,948)	$ (12,662,957)
Denominator:
Denominator for basic net loss per share - weighted average shares	2,291,746	2,267,971	2,287,328	2,265,807
Denominator for diluted net loss per share - weighted average shares	2,291,746	2,267,971	2,287,328	2,265,807
Less: weighted average shares - dilutive securities:
Net loss per common share - basic	$ (0.78)	$ (2.91)	$ (7.94)	$ (5.59)
Net loss per common share - diluted	$ (0.78)	$ (2.91)	$ (7.94)	$ (5.59)

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Schedule of Quantitative Information About Level 3 Fair Value Measurement (Details)	Dec. 31, 2024 USD ($)	Jun. 30, 2024 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Asset, Valuation Technique [Extensible Enumeration]	us-gaap:ValuationTechniqueOptionPricingModelMember
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Purchase option	$ 695,000	$ 695,000
Risk-free rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.038
Risk-free rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.049
Stock price volatility | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.60
Stock price volatility | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.65
Lack of control premium
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.13
Lack of marketability premium
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.30

Summary of Significant Accou_11

Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Recognized and Measured at Fair Value on Recurring Basis (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Level 1
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Vision Bioenergy interest purchase option	$ 0	$ 0
Total	0	0
Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Vision Bioenergy interest purchase option	0	0
Total	0	0
Level 3
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Vision Bioenergy interest purchase option	695,000	695,000
Total	$ 695,000	$ 695,000

Discontinued Operations - Sched

Discontinued Operations - Schedule of Consideration Exchanged (Details) - S&W Seed Company Australia Pty Ltd - Discontinued Operations, Disposed of by Sale - USD ($)	Dec. 31, 2024	Nov. 22, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net payables retired	$ 15,337,620
Bank guarantee released	5,000,000
Intangible assets transferred	(9,680,861)	$ (9,700,000)
Inventory transferred	(5,940,879)
TSA Liability	(123,166)
Sale of Subsidiary Gain
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on disposal of subsidiary	$ 4,592,714

Discontinued Operations - Summa

Discontinued Operations - Summary of the Operating Results of the Discontinued Operations (Details) - USD ($)		3 Months Ended		6 Months Ended
	Jul. 24, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Other (income) expense
Net (income) loss from discontinued operations		$ 4,592,714	$ (2,735,857)	$ (5,401,785)	$ (3,819,351)
S&W Seed Company Australia Pty Ltd | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue			2,603,501	842,545	8,278,620
Cost of revenue (excluding depreciation and amortization shown separately below)			2,847,132	572,862	6,237,264
Gross profit			(243,631)	269,683	2,041,356
Operating expenses
Selling, general and administrative expenses			1,650,016	276,096	3,283,034
Research and development expenses			271,054	50,713	578,677
Depreciation and amortization			257,471	47,660	519,657
Loss (gain) on disposal of property, plant and equipment			(20,453)	25,696	(31,317)
Total operating expenses			2,158,088	400,165	4,350,051
Loss from operations			(2,401,719)	(130,482)	(2,308,695)
Other (income) expense
(Gain) loss on deconsolidation of subsidiary	$ 9,828,253	(4,592,714)		5,235,539
Foreign currency loss (gain)			269,443	(120,877)	641,043
Interest expense - amortization of debt discount			98,521	6,799	197,528
Interest expense, net			625,702	149,842	1,233,190
Net (income) loss from discontinued operations before income taxes		4,592,714	(3,395,385)	(5,401,785)	(4,380,456)
Benefit for income taxes from discontinued operations			(758,818)		(745,318)
Net (income) loss from discontinued operations before equity in net earnings of affiliates		4,592,714	(2,636,567)	(5,401,785)	(3,635,138)
Equity in loss of equity method investee, net of tax, from discontinued operations			99,290		184,213
Net (income) loss from discontinued operations		$ 4,592,714	$ (2,735,857)	$ (5,401,785)	$ (3,819,351)

Discontinued Operations - Sum_2

Discontinued Operations - Summary of Assets and Liabilities of the Discontinued Operations (Details) - USD ($)	Dec. 31, 2024	Nov. 22, 2024	Jul. 24, 2024	Jun. 30, 2024
CURRENT ASSETS
TOTAL CURRENT ASSETS	$ 0			$ 22,391,691
NON-CURRENT ASSETS
NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS	0			5,578,941
CURRENT LIABILITIES
CURRENT LIABILITIES OF DISCONTINUED OPERATIONS	0			44,893,499
NON-CURRENT LIABILITIES OF DISCONTINUED OPERATIONS	$ 0			929,623
S&W Seed Company Australia Pty Ltd | Discontinued Operations
CURRENT ASSETS
Cash and cash equivalents			$ 85,876	7,506
Accounts receivable, net			6,311,994	6,228,502
Inventories, net		$ 5,900,000	15,274,546	15,478,760
Prepaid expenses and other current assets			666,509	676,923
TOTAL CURRENT ASSETS			37,888,520	22,391,691
NON-CURRENT ASSETS
Property, plant and equipment, net			3,322,273	3,540,075
Intangibles, net			554,850	576,669
Right of use assets - operating leases			1,093,946	1,134,985
Other assets			309,022	327,212
NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS				5,578,941
TOTAL ASSETS OF DISCONTINUED OPERATIONS			43,168,611	27,970,632
CURRENT LIABILITIES
Accounts payable			9,150,910	10,235,898
Deferred revenue			33,047	40,456
Accrued expenses and other current liabilities			2,947,985	3,123,721
Current portion of working capital lines of credit, net			28,263,338	27,549,620
Current portion of long-term debt, net			3,828,839	3,943,804
CURRENT LIABILITIES OF DISCONTINUED OPERATIONS			44,744,332	44,893,499
Long-term debt, net, less current portion			127,288	151,387
Other non-current liabilities			758,168	778,236
NON-CURRENT LIABILITIES OF DISCONTINUED OPERATIONS				929,623
TOTAL LIABILITIES OF DISCONTINUED OPERATIONS		$ 15,300,000	$ 45,629,788	$ 45,823,122

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Details) - USD ($)		3 Months Ended	6 Months Ended
	Jul. 24, 2024	Dec. 31, 2024	Dec. 31, 2024	Nov. 22, 2024	Jun. 30, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Bank guarantee		$ 5,000,000	$ 5,000,000
S&W Seed Company Australia Pty Ltd | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on deconsolidation of subsidiary	$ (9,828,253)	$ 4,592,714	(5,235,539)
S&W Australia total liabilities	(45,629,788)			$ (15,300,000)	$ (45,823,122)
Bank guarantee	5,000,000			5,000,000
Intangible assets transferred				9,700,000
Inventories, net	$ 15,274,546			5,900,000	$ 15,478,760
TSA Liability				$ 100,000
S&W Seed Company Australia Pty Ltd | Discontinued Operations | Maximum
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Voluntary administration process related material amount			$ 100,000

Discontinued Operations - Sch_2

Discontinued Operations - Schedule of Reconciliation of Loss On Deconsolidation of S&W Australia (Details) - USD ($)		3 Months Ended	6 Months Ended
	Jul. 24, 2024	Dec. 31, 2024	Dec. 31, 2024	Nov. 22, 2024	Jun. 30, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Recognition of bank guarantee		$ 5,000,000	$ 5,000,000
S&W Seed Company Australia Pty Ltd | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realization of currency translation adjustments from accumulated other comprehensive loss	$ 7,289,430
Recognition of bank guarantee	5,000,000			$ 5,000,000
S&W Australia total assets	43,168,611				$ 27,970,632
S&W Australia total liabilities	(45,629,788)			$ (15,300,000)	$ (45,823,122)
Loss on deconsolidation of subsidiary	$ 9,828,253	$ (4,592,714)	$ 5,235,539

Discontinued Operations - Recon

Discontinued Operations - Reconciliation of S&W Australia Total Assets and Total Liabilities (Details) - USD ($)	Dec. 31, 2024	Nov. 22, 2024	Jul. 24, 2024	Jun. 30, 2024
CURRENT ASSETS
TOTAL CURRENT ASSETS	$ 0			$ 22,391,691
Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]
CURRENT LIABILITIES OF DISCONTINUED OPERATIONS	$ 0			44,893,499
S And W Seed Company Australia Pty Limited [Member] | Discontinued Operations [Member]
CURRENT ASSETS
Cash and cash equivalents			$ 85,876	7,506
Accounts receivable, net			6,311,994	6,228,502
Receivable from unconsolidated subsidiary			15,549,595
Inventories, net		$ 5,900,000	15,274,546	15,478,760
Prepaid expenses and other current assets			666,509	676,923
TOTAL CURRENT ASSETS			37,888,520	22,391,691
Property, plant and equipment, net			3,322,273	3,540,075
Other intangibles, net			554,850	576,669
Right of use assets - operating leases			1,093,946	1,134,985
Other assets			309,022	327,212
TOTAL ASSETS OF DISCONTINUED OPERATIONS			43,168,611	27,970,632
Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]
Accounts payable			9,150,910	10,235,898
Payable to unconsolidated subsidiary			520,213
Deferred revenue			33,047	40,456
Accrued expenses and other current liabilities			2,947,985	3,123,721
Current portion of working capital lines of credit, net			28,263,338	27,549,620
Current portion of long-term debt, net			3,828,839	3,943,804
CURRENT LIABILITIES OF DISCONTINUED OPERATIONS			44,744,332	44,893,499
Long-term debt, net, less current portion			127,288	151,387
Other non-current liabilities			758,168	778,236
TOTAL LIABILITIES OF DISCONTINUED OPERATIONS		$ 15,300,000	$ 45,629,788	$ 45,823,122

Leases - Summary of Components

Leases - Summary of Components of Lease Assets and Liabilities (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Lessee Disclosure [Abstract]
Right of use assets - finance leases	$ 994,539	$ 1,086,667
Accumulated amortization - finance leases	(569,207)	(499,275)
Right of use assets - finance leases, net	$ 425,332	$ 587,392
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets	Other assets
Right of use assets - operating leases	$ 810,018	$ 1,113,833
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Right of use assets - operating leases	Right of use assets - operating leases
Total lease assets	$ 1,235,350	$ 1,701,225
Current lease liabilities - finance leases	$ 291,250	$ 314,980
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Current portion of long-term debt, net	Current portion of long-term debt, net
Current lease liabilities - operating leases	$ 314,346	$ 380,492
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Long-term portion of lease liabilities - finance leases	$ 159,026	$ 303,395
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt, net, less current portion	Long-term debt, net, less current portion
Long-term portion of lease liabilities - operating leases	$ 585,435	$ 800,620
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other non-current liabilities	Other non-current liabilities
Total lease liabilities	$ 1,350,057	$ 1,799,487

Leases - Summary of Component_2

Leases - Summary of Components of Lease Cost (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Lessee Lease Description [Line Items]
Total lease costs	$ 216,281	$ 314,746	$ 428,922	$ 485,463
Cost of Revenue
Lessee Lease Description [Line Items]
Operating lease cost	60,766	96,092	121,533	175,666
Selling, General and Administrative Expenses
Lessee Lease Description [Line Items]
Operating lease cost	25,993	36,542	59,019	41,052
Research and Development Expenses
Lessee Lease Description [Line Items]
Operating lease cost	21,310	71,824	42,619	119,227
Depreciation and Amortization
Lessee Lease Description [Line Items]
Finance lease cost	81,713	90,290	165,088	119,469
Interest expense, net
Lessee Lease Description [Line Items]
Finance lease cost	$ 26,499	$ 19,998	$ 40,663	$ 30,049

Leases - Summary of Maturities

Leases - Summary of Maturities of Lease Liabilities (Details)	Dec. 31, 2024 USD ($)
Operating Leases
Remainder of 2025	$ 203,676
2026	354,960
2027	241,622
2028	183,599
2029	56,965
Total lease payments	1,040,822
Less: Interest	(141,041)
Present value of lease liabilities	899,781
Finance Leases
Remainder of 2025	162,853
2026	280,892
2027	44,615
2028	0
2029	0
Total lease payments	488,360
Less: Interest	(38,084)
Present value of lease liabilities	$ 450,276

Leases - Summary of Weighted Av

Leases - Summary of Weighted Average Assumptions on Lease Term and Discount Rate and Supplemental Cash Flow Information Related to Leases (Details)	6 Months Ended
	Dec. 31, 2024 USD ($)
Lessee Disclosure [Abstract]
Operating lease remaining lease term	3 years 1 month 6 days
Operating lease discount rate	8.65%
Finance lease remaining lease term	1 year 4 months 24 days
Finance lease discount rate	9.49%
Cash paid for operating leases	$ 221,650
Cash paid for finance leases	$ 191,247

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Revenue Recognition [Line Items]
Maximum term of payments for transfer goods and services			1 year
Bad debt expense	$ 400,000	$ 300,000	$ 200,000	$ 500,000
Revenue recognized			300,000	400,000
Revenue	5,076,898	8,261,308	13,386,374	19,018,655
Vision Bioenergy
Revenue Recognition [Line Items]
Unbilled receivables	100,000		100,000		$ 200,000
ADAMA Collaboration Agreement | Seed Sales
Revenue Recognition [Line Items]
Revenue	$ 1,900,000	$ 4,000,000	$ 1,800,000	$ 4,500,000
Minimum
Revenue Recognition [Line Items]
Term of customer invoice payment			30 days
Maximum
Revenue Recognition [Line Items]
Term of customer invoice payment			180 days

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Disaggregation Of Revenue [Line Items]
Total revenue	$ 5,076,898	$ 8,261,308	$ 13,386,374	$ 19,018,655
Alfalfa
Disaggregation Of Revenue [Line Items]
Total revenue	1,734,054	2,299,360	8,442,056	9,385,730
Sorghum
Disaggregation Of Revenue [Line Items]
Total revenue	2,970,610	5,764,167	4,403,468	9,274,134
Other
Disaggregation Of Revenue [Line Items]
Total revenue	238,021	21,993	249,245	(24,656)
Services
Disaggregation Of Revenue [Line Items]
Total revenue	$ 134,213	$ 175,788	$ 291,605	$ 383,447

Revenue Recognition - Schedule

Revenue Recognition - Schedule of Revenues and Percentage of Revenue from External Customers by Country (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 5,076,898	$ 8,261,308	$ 13,386,374	$ 19,018,655
Revenue from external customers by country, percentage	100%	100%	100%	100%
United States
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 4,800,636	$ 5,248,009	$ 7,735,352	$ 8,262,250
Revenue from external customers by country, percentage	95%	64%	58%	43%
Libya
Disaggregation of Revenue [Line Items]
Revenues from external customers		$ 682,200	$ 1,295,550	$ 1,755,000
Revenue from external customers by country, percentage	0%	8%	10%	9%
Mexico
Disaggregation of Revenue [Line Items]
Revenues from external customers		$ 1,904,895	$ 1,052,781	$ 3,467,712
Revenue from external customers by country, percentage	0%	23%	8%	18%
Sudan
Disaggregation of Revenue [Line Items]
Revenues from external customers			$ 807,530	$ 1,267,933
Revenue from external customers by country, percentage	0%	0%	6%	7%
South Africa
Disaggregation of Revenue [Line Items]
Revenues from external customers			$ 533,125	$ 1,195,553
Revenue from external customers by country, percentage	0%	0%	4%	6%
Egypt
Disaggregation of Revenue [Line Items]
Revenues from external customers		$ 348,000	$ 496,360	$ 348,000
Revenue from external customers by country, percentage	0%	4%	4%	2%
Uganda
Disaggregation of Revenue [Line Items]
Revenues from external customers		$ 289,935	$ 299,640	$ 329,935
Revenue from external customers by country, percentage	0%	4%	2%	2%
Morocco
Disaggregation of Revenue [Line Items]
Revenues from external customers			$ 287,994
Revenue from external customers by country, percentage	0%	0%	2%	0%
Bolivia
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 112,750		$ 180,000
Revenue from external customers by country, percentage	2%	0%	1%	0%
Argentina
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 61,479		$ 150,769	$ 35,400
Revenue from external customers by country, percentage	1%	0%	1%	0%
Saudi Arabia
Disaggregation of Revenue [Line Items]
Revenues from external customers		$ (211,185)		$ 1,997,553
Revenue from external customers by country, percentage	0%	(3.00%)	0%	11%
Other
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 102,033	$ (546)	$ 547,273	$ 359,319
Revenue from external customers by country, percentage	2%	0%	4%	2%

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	$ 19,976,654		$ 19,976,654		$ 41,410,524
Intangible accumulated amortization	(6,979,430)		(6,979,430)		(17,938,186)
Intangible asset	12,997,224		12,997,224		23,472,338
Intangible disposal			(9,680,861)
Intangible amortization expense	(300,000)	$ (500,000)	(794,254)	$ (900,000)
Intellectual Property
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	13,491,466		13,491,466		33,325,737
Intangible accumulated amortization	(2,881,149)		(2,881,149)		(13,060,119)
Intangible asset	10,610,317		10,610,317		20,265,618
Intangible disposal			(9,068,039)
Intangible amortization expense			(587,262)
Trade Name
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	232,329		232,329		1,831,928
Intangible accumulated amortization	(225,992)		(225,992)		(1,178,972)
Intangible asset	6,337		6,337		652,956
Intangible disposal			(612,822)
Intangible amortization expense			(33,798)
Customer Relationships
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	1,596,653		1,596,653		1,596,653
Intangible accumulated amortization	(1,064,826)		(1,064,826)		(1,019,623)
Intangible asset	531,827		531,827		577,030
Intangible amortization expense			(45,203)
GI Customer list
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	121,786		121,786		121,786
Intangible accumulated amortization	(96,713)		(96,713)		(93,131)
Intangible asset	25,073		25,073		28,655
Intangible amortization expense			(3,582)
Supply Agreement
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	1,512,667		1,512,667		1,512,667
Intangible accumulated amortization	(926,509)		(926,509)		(888,692)
Intangible asset	586,158		586,158		623,975
Intangible amortization expense			(37,817)
Grower Relationships
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	2,343,977		2,343,977		2,343,977
Intangible accumulated amortization	(1,275,911)		(1,275,911)		(1,223,208)
Intangible asset	1,068,066		1,068,066		1,120,769
Intangible amortization expense			(52,703)
Internal use software
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	677,776		677,776		677,776
Intangible accumulated amortization	(508,330)		(508,330)		(474,441)
Intangible asset	$ 169,446		169,446		$ 203,335
Intangible amortization expense			$ (33,889)

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Nov. 22, 2024
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 300,000	$ 500,000	$ 794,254	$ 900,000
S&W Seed Company Australia Pty Ltd | Discontinued Operations, Disposed of by Sale
Finite-Lived Intangible Assets [Line Items]
Intangible assets transferred	$ 9,680,861		9,680,861		$ 9,700,000
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			587,262
Intellectual Property [Member] | S&W Seed Company Australia Pty Ltd | Discontinued Operations, Disposed of by Sale
Finite-Lived Intangible Assets [Line Items]
Intangible assets transferred					9,100,000
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			$ 33,798
Trade Names [Member] | S&W Seed Company Australia Pty Ltd | Discontinued Operations, Disposed of by Sale
Finite-Lived Intangible Assets [Line Items]
Intangible assets transferred					$ 600,000

Intangible Assets - Estimated A

Intangible Assets - Estimated Aggregate Remaining Amortization (Details)	Dec. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2025	$ 458,673
2026	900,605
2027	849,721
2028	795,496
2029	785,319
Thereafter	$ 9,207,410

Property, Plant and Equipment -

Property, Plant and Equipment - Components of Property, Plant and Equipment (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	$ 12,853,779	$ 12,809,793
Less: accumulated depreciation	(7,121,295)	(6,682,595)
Property, plant and equipment, net	5,732,484	6,127,198
Land and improvements
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	586,849	586,849
Buildings and improvements
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	2,365,835	2,371,565
Machinery and Equipment
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	8,784,859	8,621,280
Vehicles
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	642,929	648,836
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	473,307	552,810
Construction in progress
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	$ 0	$ 28,453

Property, Plant and Equipment_2

Property, Plant and Equipment - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 0.3	$ 0.3	$ 0.6	$ 0.5

Investments - Additional Inform

Investments - Additional Information (Details)	Dec. 31, 2024	Jun. 30, 2024
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Ownership interest	34%	34%

Investments - Summary of Financ

Investments - Summary of Financial Information of Unaudited Balance Sheet (Details) - USD ($)	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023
Schedule of Equity Method Investments [Line Items]
Cash	$ 1,393,200		$ 286,508
Intangible assets	12,997,224		23,472,338
Other assets	1,461,381		1,364,532
TOTAL ASSETS	73,322,013		120,725,541
Current liabilities	33,153,382		69,242,324
Equity	28,963,859	$ 30,521,192	39,262,360	$ 56,786,138	$ 62,828,906	$ 68,823,433
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	73,322,013		120,725,541
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Cash	6,804,663		6,327,459
Other current assets	6,944,995		3,138,627
Fixed assets	17,592,974		17,866,091
Intangible assets	18,327,881		19,624,187
Goodwill	11,564,157		11,564,157
Other assets	131,468		235,613
TOTAL ASSETS	61,366,138		58,756,134
Current liabilities	4,781,810		1,485,283
Long-term liabilities	59,760		133,070
Equity	56,524,568		57,137,781
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	$ 61,366,138		$ 58,756,134

Investments - Summary of Fina_2

Investments - Summary of Financial Information of Unaudited Income Statement (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Revenue	$ 5,076,898	$ 8,261,308	$ 13,386,374	$ 19,018,655
Gross income (loss)	1,882,522	3,532,755	3,218,891	6,259,082
Loss from operations	(4,344,263)	(2,204,012)	(8,577,840)	(5,194,881)
Net loss	(1,660,857)	(6,468,852)	(17,890,583)	(12,418,481)
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Revenue	355,864	1,074,934	663,635	1,228,924
Gross income (loss)	(68,334)	619,646	(554,606)	(327,005)
Loss from operations	(2,160,801)	(1,794,747)	(4,658,726)	(4,624,553)
Net loss	$ (2,126,718)	$ (1,750,017)	$ (4,573,213)	$ (4,509,196)

Investments - Schedule of Carry

Investments - Schedule of Carrying Amount of The Company's Equity Method Investments (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Schedule of Equity Method Investments [Line Items]
Total equity method investments, Carrying Amount	$ 18,122,435	$ 19,694,209
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Total equity method investments, Carrying Amount	$ 18,122,435	$ 19,694,209
Economic Interest	34%	34%

Investments - Schedule of Compa

Investments - Schedule of Company's Equity Method Investments (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Beginning balance			$ 19,694,209
Equity in loss of equity method investment	$ (724,895)	$ (577,039)	(1,571,775)	$ (1,354,012)
Ending balance	18,122,435		18,122,435
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Beginning balance			19,694,209
Equity in loss of equity method investment			(1,571,774)
Ending balance	$ 18,122,435		$ 18,122,435

Debt - Schedule of Total Debt O

Debt - Schedule of Total Debt Outstanding (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Current portion of working capital lines of credit
Total current portion of working capital lines of credit, net	$ 13,733,741	$ 16,174,537
Total working capital lines of credit, net	13,733,741	16,174,537
Current portion of long-term debt
Finance leases, Current	$ 291,250	$ 314,980
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Total current portion, net	Total current portion, net
Debt issuance costs, Current	$ (106,528)	$ (106,528)
Total current portion, net	267,848	315,304
Long-term debt, less current portion
Finance leases, Noncurrent	$ 159,026	$ 303,395
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Long-Term Debt and Lease Obligation	Long-Term Debt and Lease Obligation
Debt issuance costs, Noncurrent	$ (49,907)	$ (103,609)
Total long-term portion, net	4,591,207	4,721,849
Total debt, net	4,859,055	5,037,153
Mountain Ridge
Current portion of working capital lines of credit
Total current portion of working capital lines of credit, net	13,733,741	0
Current portion of long-term debt
Debt issuance costs, Current	(1,000,000)
CIBC
Current portion of working capital lines of credit
Total current portion of working capital lines of credit, net	0	16,279,194
Current portion of long-term debt
Debt issuance costs, Current	0	(104,657)
Vehicle Loans | Ford Credit
Current portion of long-term debt
Secured Debt, Current	83,126	106,852
Long-term debt, less current portion
Secured Long-term Debt, Noncurrent	182,088	222,063
AgAmerica RE Long
Long-term debt, less current portion
Secured Long-term Debt, Noncurrent	$ 4,300,000	$ 4,300,000

Debt - Mountain Ridge Credit Ag

Debt - Mountain Ridge Credit Agreement - Additional Information (Details) - USD ($)			6 Months Ended
	Dec. 19, 2024	Jun. 20, 2023	Dec. 31, 2024	Jun. 30, 2024
Line of Credit Facility [Line Items]
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	SOFR
Debt issuance costs			$ 106,528	$ 106,528
Prepaid expenses and other current assets			$ 3,412,588	$ 3,431,226
Term Loan Agreement
Line of Credit Facility [Line Items]
Debt Instrument, Maturity Date		Dec. 22, 2025
Mountain Ridge
Line of Credit Facility [Line Items]
Line of credit and security agreement date	Dec. 19, 2024
Line of Credit Facility, Maximum Borrowing Capacity	$ 25,000,000
Debt Instrument, Maturity Date	Feb. 20, 2026
Debt instrument extended maturity date			Dec. 19, 2027
Line of credit facility, borrowing capacity, description	Availability of funds under the Mountain Ridge Credit Facility is subject to a borrowing base equal to the sum of (i) up to 95% of eligible letters of credit, plus (ii) up to 70% of eligible accounts (provided, that the maximum amount of eligible accounts that constitute (y) seasonal domestic accounts
Borrowing base in percentage based on eligible line of credit	95%
Borrowing base in percentage based on eligible domestic accounts receivable	70%
Borrowing base value of an eligible foreign account	$ 3,500,000
Borrowing base value of an eligible inventory	$ 10,000,000
Borrowing Base In Percentage Based On Eligible Inventory	50%
Basis spread on variable rate	8%
Debt instrument, interest rate			12.53%
Debt instrument, debt default, Increase in interest rate per annum	2%
Line of credit facility, remaining borrowing capacity			$ 1,600,000
Line of credit facility, current borrowing capacity			25,000,000
Debt issuance costs			1,000,000
Amortized			0
Prepaid expenses and other current assets			$ 1,000,000
Mountain Ridge | From October 1 through January 31
Line of Credit Facility [Line Items]
Borrowing base value of an eligible domestic accounts	$ 3,000,000
Mountain Ridge | From Feburary 1 through Feburary 28
Line of Credit Facility [Line Items]
Borrowing base value of an eligible domestic accounts	4,000,000
Mountain Ridge | From March 1 through September 30
Line of Credit Facility [Line Items]
Borrowing base value of an eligible domestic accounts	5,000,000
Mountain Ridge | From April 1 through June 30
Line of Credit Facility [Line Items]
Borrowing base value of an eligible domestic accounts	$ 6,000,000
AgAmerica
Line of Credit Facility [Line Items]
Term loan agreement date		Jun. 20, 2023
AgAmerica | Term Loan Agreement
Line of Credit Facility [Line Items]
Debt instrument extended maturity date			Mar. 19, 2028

Debt - CIBC Credit Facility - A

Debt - CIBC Credit Facility - Additional Information (Details) - USD ($)	Dec. 19, 2024	Nov. 29, 2024	Nov. 27, 2024	Oct. 31, 2024	Sep. 18, 2024	Jul. 16, 2024	Jul. 03, 2024	Jul. 01, 2024	Mar. 22, 2023	Dec. 26, 2019	Oct. 01, 2024
Letter of Credit
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									$ 13,000,000
Debt instrument, maturity date	Jan. 31, 2028		Jan. 31, 2025			Nov. 30, 2024			Sep. 30, 2024
CIBC
Line Of Credit Facility [Line Items]
Line of credit and security agreement date										Dec. 26, 2019
Line of credit facility, maximum borrowing capacity										$ 35,000,000
Debt instrument, maturity date		Dec. 13, 2024		Nov. 30, 2024			Oct. 31, 2024		Aug. 31, 2024
Increased applicable interest rate margin on advances					2%
Loan agreement fees		$ 40,000		$ 25,000			$ 15,000	$ 10,000
CIBC | From July 1, 2024 through August 31, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit							5,000,000
CIBC | From July 1, 2024 through July 14, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit							8,500,000
CIBC | From July 15, 2024 through August 14, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit							7,500,000
CIBC | From August 15, 2024 through September 15, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit							7,000,000
CIBC | From September 16, 2024 through September 29, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit							6,500,000
CIBC | From September 30, 2024 through the Maturity Date
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit							5,000,000
CIBC | Line of Credit
Line Of Credit Facility [Line Items]
Loan agreement fees											$ 25,000
CIBC | Line of Credit | From July 1, 2024 through July 31, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity							20,000,000
CIBC | Line of Credit | From August 1, 2024 through September 1, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity							18,500,000
CIBC | Line of Credit | From September 2, 2024 through September 15, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity							17,500,000
CIBC | Line of Credit | From September 16, 2024 through October 9, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity							15,000,000
CIBC | Line of Credit | From October 10, 2024 through Maturity Date
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity							$ 13,000,000
CIBC | Minimum
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit								$ 5,000,000

Debt - AgAmerica Note - Additio

Debt - AgAmerica Note - Additional Information (Details) $ in Millions	Dec. 19, 2024	Jun. 20, 2023 USD ($) Acres	Dec. 31, 2024
Line of Credit Facility [Line Items]
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
AgAmerica
Line of Credit Facility [Line Items]
Term loan agreement date		Jun. 20, 2023
Secured Real Estate Note | AgAmerica
Line of Credit Facility [Line Items]
Debt face amount | $		$ 4.3
Number of acres of land held as security | Acres		31
Basis spread on variable rate		4.85%
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]		Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt instrument, annual interest rate			9.34%

Debt - MFP Loan Agreement - Add

Debt - MFP Loan Agreement - Additional Information (Details) - USD ($)	Dec. 19, 2024	Nov. 27, 2024	Oct. 31, 2024	Jul. 16, 2024	Mar. 22, 2023	Dec. 31, 2024	Jun. 30, 2024	Sep. 22, 2022
Line of Credit Facility [Line Items]
Facility outstanding amount						$ 13,733,741	$ 16,174,537
Mountain Ridge
Line of Credit Facility [Line Items]
Debt instrument, maturity date	Feb. 20, 2026
Line of credit facility, maximum borrowing capacity	$ 25,000,000
Debt instrument, interest rate						12.53%
Basis spread on variable rate	8%
Standby Letters of Credit
Line of Credit Facility [Line Items]
Debt instrument, maturity date	Jan. 31, 2028	Jan. 31, 2025		Nov. 30, 2024	Sep. 30, 2024
Line of credit facility, maximum borrowing capacity					$ 13,000,000
Debt face amount								$ 9,000,000
Letter of credit | Mountain Ridge
Line of Credit Facility [Line Items]
Debt face amount								13,000,000
MFP Loan Agreement
Line of Credit Facility [Line Items]
Debt instrument, maturity date	Jul. 31, 2028			May 31, 2025
Line of credit facility, maximum borrowing capacity								$ 9,000,000
Line of credit facility, unused capacity commitment fee percentage				4.25%
Debt instrument, percentage of interest payable in cash				50%
Debt instrument, percentage of interest paid in kind				50%
Facility outstanding amount						$ 0
MFP Loan Agreement | Standby Letters of Credit
Line of Credit Facility [Line Items]
Debt instrument, maturity date			Dec. 31, 2024
MFP Loan Agreement | Reference Rate Floor
Line of Credit Facility [Line Items]
Debt instrument, interest rate				1.25%
MFP Loan Agreement | SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate				9.25%

Debt - Schedule of Annual Matur

Debt - Schedule of Annual Maturities of Long-Term Debt Excluding Finance Lease Liabilites (Details)	Dec. 31, 2024 USD ($)
Debt Disclosure [Abstract]
Remainder of 2025	$ 47,548
2026	4,395,096
2027	95,096
2028	27,474
Total	$ 4,565,214

Business Segments - Additional

Business Segments - Additional Information (Details)	6 Months Ended
	Dec. 31, 2024 Segment
Segment Reporting [Abstract]
Number of operating segments	2
Number of reportable segments	2

Business Segments - Summary of

Business Segments - Summary of Business Activity by Segment (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Revenue
Revenue	$ 5,076,898	$ 8,261,308	$ 13,386,374	$ 19,018,655
Gross profit (excluding depreciation and amortization)
Gross profit (excluding depreciation and amortization)	1,882,522	3,532,755	3,218,891	6,259,082
Americas
Revenue
Revenue	5,072,734	7,148,131	9,205,668	12,002,183
Gross profit (excluding depreciation and amortization)
Gross profit (excluding depreciation and amortization)	1,914,232	3,356,633	2,642,495	4,309,295
International
Revenue
Revenue	994	1,113,177	4,090,001	7,016,472
Gross profit (excluding depreciation and amortization)
Gross profit (excluding depreciation and amortization)	(23,003)	176,122	774,180	1,949,787
Other
Revenue
Revenue	3,170	0	90,705	0
Gross profit (excluding depreciation and amortization)
Gross profit (excluding depreciation and amortization)	$ (8,707)	$ 0	$ (197,784)	$ 0

Equity - Additional Information

Equity - Additional Information (Details) $ / shares in Units, $ in Millions					3 Months Ended		6 Months Ended
	Dec. 19, 2024 shares	Oct. 17, 2024	Sep. 26, 2024	Mar. 22, 2023	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($)	Mar. 31, 2024 shares
Class Of Stock [Line Items]
Reverse stock split term		The terms of the Reverse Stock Split are such that every 19 shares of the Company’s issued and outstanding common stock were automatically combined into one issued and outstanding share of common stock, without any change in par value per share.
Repurchases of common stock	200,000
MFP Loan Agreement
Class Of Stock [Line Items]
Warrants to purchase of common stock									138,602
Warrant expiration term				5 years
Interest expense amortized | $					$ 0	$ 0.2	$ 0.2	$ 0.4
MFP Loan Agreement | Minimum
Class Of Stock [Line Items]
Warrant exercise price per share | $ / shares					$ 30.4		$ 30.4
MFP Loan Agreement | Maximum
Class Of Stock [Line Items]
Warrant exercise price per share | $ / shares					$ 40.85		$ 40.85
Common Stock
Class Of Stock [Line Items]
Reverse stock split ratio		0.053
Repurchases of common stock					200,000		200,000
Common Stock | Minimum
Class Of Stock [Line Items]
Reverse stock split ratio			0.2
Common Stock | Maximum
Class Of Stock [Line Items]
Reverse stock split ratio			0.05

Equity-Based Compensation - Sch

Equity-Based Compensation - Schedule of Weighted Average Assumptions (Details) - Employee Stock Option	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk free rate	4.14%
Risk free rate, minimum		4.45%
Risk free rate, maximum		4.78%
Volatility	75.30%
Volatility, minimum		70.30%
Volatility, maximum		70.60%
Forfeiture rate	8.40%	10.60%

Equity-Based Compensation - Add

Equity-Based Compensation - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted			274,764
Exercise price, lower range limit			$ 2.3
Stock-based compensation	$ 300,000	$ 300,000	$ 500,000	$ 700,000
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period			3 years
Stock options, term			10 years
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, total compensation cost not yet recognized, period for recognition			1 year 2 months 12 days
Number of restricted stock units issued			70,131	47,741
Fair value of awards granted			$ 400,000	$ 500,000
Unrecognized stock compensation expense related to restricted stock units	$ 500,000		$ 500,000
Maximum | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period			3 years
Minimum | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period			1 year
2019 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for issuance of grants	230,380		230,380
2009 and 2019 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock compensation expense, net of estimated forfeitures, related to options	$ 500,000		$ 500,000
Stock-based compensation, total compensation cost not yet recognized, period for recognition			2 years 4 months 24 days

Equity-Based Compensation - Sum

Equity-Based Compensation - Summary of Stock Option Activity (Details) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2024	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Options, Outstanding as of beginning of period	279,709
Options, Granted	274,764
Options, Exercised	0
Options, Canceled/forfeited/expired	(16,507)
Options, Outstanding as of end of period	537,966	279,709
Options, vested and exercisable at end of period	240,756
Options, vested and expected to vest	537,133
Weighted-Average Exercise Prices, Outstanding as of beginning of period	$ 39.18
Weighted-Average Exercise Prices, Granted	2.3
Weighted-Average Exercise Prices, Exercised	0
Weighted-Average Exercise Prices, Canceled/forfeited/expired	29.06
Weighted-Average Exercise Prices, Outstanding as of end of period	20.65	$ 39.18
Weighted-Average Exercise Prices, vested and exercisable	42.2
Weighted-Average Exercise Price, vested and expected to vest	$ 20.68
Options Outstanding, Weighted-Average Remaining Contractual Term (in years)	7 years 10 months 24 days	6 years 9 months 18 days
Weighted-Average Remaining Contractual Term (in years), vested and exercisable	5 years 7 months 6 days
Weighted-Average Remaining Contractual Term (in years), vested and expected to vest	7 years 10 months 24 days
Options, Outstanding, Aggregate Intrinsic Value	$ 0
Options, vested and exercisable, Aggregate Intrinsic Value	0
Options, vested and expected to vest, Aggregate Intrinsic Value	$ 0

Equity-Based Compensation - S_2

Equity-Based Compensation - Summary of Activity Related to Non-Vested Restricted Stock Units (Details) - Restricted Stock Units - $ / shares	6 Months Ended		12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Nonvested Restricted Stock Units Outstanding, Beginning	64,602
Number of Nonvested Restricted Stock Units, Granted	70,131	47,741
Number of Nonvested Restricted Stock Units, Vested	(58,499)
Number of Nonvested Restricted Stock Units, Forfeited	(1,790)
Number of Nonvested Restricted Stock Units Outstanding, Ending	74,444		64,602
Weighted-Average Grant Date Fair Value, Beginning	$ 11.40
Weighted-Average Grant Date Fair Value, Granted	11.35
Weighted-Average Grant Date Fair Value, Vested	10.18
Weighted-Average Grant Date Fair Value, Forfeited	16.26
Weighted-Average Grant Date Fair Value, Ending	$ 6.97		$ 11.40
Weighted-Average Remaining Vesting Period (Years)	1 year 2 months 12 days		1 year 2 months 12 days
Weighted-Average Remaining Vesting Period (Years), Granted	1 year 3 months 18 days

Series B Redeemable Convertib_3

Series B Redeemable Convertible Preferred Stock - Additional Information (Details)	6 Months Ended
	Dec. 31, 2024 shares
MEZZANINE EQUITY
Temporary Equity [Line Items]
Issuances and conversion of preferred stock to common stock	0

Series B Redeemable Convertib_4

Series B Redeemable Convertible Preferred Stock - Summary of Changes to Series B Convertible Preferred Stock (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Temporary Equity Disclosure [Abstract]
Mezzanine Equity Beginning Balance, amount			$ 5,768,765
Dividends accrued	$ 105,635	$ 98,593	207,689	$ 192,800
Accretion of discount for warrants			51,676	$ 51,676
Mezzanine Equity Ending Balance, amount	$ 6,028,130		$ 6,028,130

Non-Cash Activities for State_3

Non-Cash Activities for Statements of Cash Flows - Schedule of Condensed Consolidated Statements of Cash Flows for Non-Cash Activities (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Non-cash investing activities:
ROU assets financed by lease liabilities and lease modifications and reassessments			$ (96,693)	$ 1,078,774
Non-cash financing activities:
Dividends accrued for participating securities	$ 105,635	$ 98,593	207,689	192,800
Accretion of discount for series B preferred stock warrants			51,676	$ 51,676
S&W Seed Company Australia Pty Ltd
Considerations with Avior for transfer of interest in S&W Australia (discontinued operations):
Settlement of net payables due			15,336,849
Contribution of intangible assets			(9,680,861)
Contribution of inventory			$ (5,940,878)